<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">mBio</journal-id><journal-id journal-id-type="iso-abbrev">mBio</journal-id><journal-id journal-id-type="pmc-domain-id">1266</journal-id><journal-id journal-id-type="pmc-domain">mbio</journal-id><journal-id journal-id-type="publisher-id">mbio</journal-id><journal-title-group><journal-title>mBio</journal-title></journal-title-group><issn pub-type="epub">2150-7511</issn><publisher><publisher-name>American Society for Microbiology (ASM)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10790774</article-id><article-id pub-id-type="pmcid-ver">PMC10790774.1</article-id><article-id pub-id-type="pmcaid">10790774</article-id><article-id pub-id-type="pmcaiid">10790774</article-id><article-id pub-id-type="pmid">38112418</article-id><article-id pub-id-type="doi">10.1128/mbio.03036-23</article-id><article-id pub-id-type="publisher-id">03036-23</article-id><article-id pub-id-type="publisher-id">mbio.03036-23</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Minireview</subject></subj-group><subj-group subj-group-type="biological-terms"><compound-subject><compound-subject-part content-type="code">immunology</compound-subject-part><compound-subject-part content-type="label">Immunology</compound-subject-part></compound-subject></subj-group></article-categories><title-group><article-title>Understanding Fc function for rational vaccine design against pathogens</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4222-5286</contrib-id><name name-style="western"><surname>Bowman</surname><given-names initials="KA">Kathryn A.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Kaplonek</surname><given-names initials="P">Paulina</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8866-3532</contrib-id><name name-style="western"><surname>McNamara</surname><given-names initials="RP">Ryan P.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role><email>rpmcnamara@mgh.harvard.edu</email></contrib><aff id="aff1"><label>1</label><institution-wrap><institution>Ragon Institute of MGH, MIT, and Harvard</institution></institution-wrap>, <city>Cambridge</city>, <state>Massachusetts</state>, <country>USA</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution>Division of Infectious Diseases, Brigham and Women&#8217;s Hospital</institution></institution-wrap>, <city>Boston</city>, <state>Massachusetts</state>, <country>USA</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><role>Editor</role><name name-style="western"><surname>Yount</surname><given-names initials="J">Jacob</given-names></name><aff><institution-wrap><institution>Ohio State University</institution></institution-wrap>, <city>Columbus</city>, <state>Ohio</state>, <country>USA</country></aff></contrib></contrib-group><author-notes><corresp id="cor1">Address correspondence to Ryan P. McNamara, <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:rpmcnamara@mgh.harvard.edu">rpmcnamara@mgh.harvard.edu</email></corresp><fn fn-type="equal"><p>Kathryn A. Bowman and Paulina Kaplonek contributed equally to this article. Authorship order was determined by alphabetical order of the two co-first authors&#8217; last names.</p></fn><fn fn-type="COI-statement"><p>The authors declare no conflict of interest.</p></fn></author-notes><pub-date publication-format="electronic" date-type="collection"><month>1</month><year>2024</year></pub-date><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>12</month><year>2023</year></pub-date><volume>15</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">453497</issue-id><elocation-id>e03036-23</elocation-id><pub-history><event event-type="pmc-release"><date><day>19</day><month>12</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>17</day><month>01</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-12-06 12:25:17.080"><day>06</day><month>12</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2023 Bowman et al.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Bowman et al.</copyright-holder><ali:free_to_read start_date="2023-12-19"/><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="mbio.03036-23.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="mbio.03036-23.pdf"/><abstract abstract-type="primary"><title>ABSTRACT</title><p>Antibodies represent the primary correlate of immunity following most clinically approved vaccines. However, their mechanisms of action vary from pathogen to pathogen, ranging from neutralization, to opsonophagocytosis, to cytotoxicity. Antibody functions are regulated both by antigen specificity (Fab domain) and by the interaction of their Fc domain with distinct types of Fc receptors (FcRs) present in immune cells. Increasing evidence highlights the critical nature of Fc:FcR interactions in controlling pathogen spread and limiting the disease state. Moreover, variation in Fc-receptor engagement during the course of infection has been demonstrated across a range of pathogens, and this can be further influenced by prior exposure(s)/immunizations, age, pregnancy, and underlying health conditions. Fc:FcR functional variation occurs at the level of antibody isotype and subclass selection as well as post-translational modification of antibodies that shape Fc:FcR-interactions. These factors collectively support a model whereby the immune system actively harnesses and directs Fc:FcR interactions to fight disease. By defining the precise humoral mechanisms that control infections, as well as understanding how these functions can be actively tuned, it may be possible to open new paths for improving existing or novel vaccines.</p></abstract><kwd-group><title>KEYWORDS</title><kwd>antibody</kwd><kwd>Fc receptor</kwd><kwd>Fc-effector function</kwd><kwd>vaccine</kwd><kwd>vaccine design</kwd></kwd-group><funding-group specific-use="FundRef"><award-group award-type="grant" id="award-1"><funding-source><institution-wrap><institution>HHS | National Institutes of Health (NIH)</institution></institution-wrap></funding-source><award-id>1P01AI165072-01</award-id><principal-award-recipient><name name-style="western"><surname>McNamara</surname><given-names>Ryan P.</given-names></name></principal-award-recipient></award-group><award-group award-type="grant" id="award-2"><funding-source><institution-wrap><institution>HHS | National Institutes of Health (NIH)</institution></institution-wrap></funding-source><award-id>75N93019C00071</award-id><principal-award-recipient><name name-style="western"><surname>McNamara</surname><given-names>Ryan P.</given-names></name></principal-award-recipient></award-group><award-group award-type="grant" id="award-3"><funding-source><institution-wrap><institution>HHS | National Institutes of Health (NIH)</institution></institution-wrap></funding-source><award-id>5U19AI135995-05</award-id><principal-award-recipient><name name-style="western"><surname>McNamara</surname><given-names>Ryan P.</given-names></name></principal-award-recipient></award-group><award-group award-type="grant" id="award-4"><funding-source><institution-wrap><institution>Bill and Melinda Gates Foundation (GF)</institution></institution-wrap></funding-source><award-id>INV-031624</award-id><principal-award-recipient><name name-style="western"><surname>McNamara</surname><given-names>Ryan P.</given-names></name></principal-award-recipient></award-group></funding-group><counts><count count="0" count-type="supplementary-material"/><count count-type="authors" count="3"/><fig-count count="2"/><ref-count count="176"/><page-count count="19"/><word-count count="14349"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Vaccine campaigns to date have resulted in a significant reduction of morbidity and mortality across the ages, estimated to prevent approximately 2&#8211;3 million deaths annually (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). However, new vaccines are still urgently needed to combat widely circulating agents such as <italic toggle="yes">Mycobacterium tuberculosis</italic>, human immunodeficiency virus (HIV), <italic toggle="yes">Plasmodium</italic>, SARS-related coronaviruses, etc. In addition, new vaccination strategies are needed to address disease prevalence in vulnerable populations that respond poorly to current vaccine strategies such as the elderly, neonates, immunocompromised, etc. Thus, while existing vaccine platforms have successfully revolutionized the battle against many pathogens to date, a deeper appreciation of immune mechanisms of protection is needed for next-generation formulations and platforms.</p><p>Induction of antibodies represents the primary correlate of protection against infection/disease for most vaccines (<xref rid="B3" ref-type="bibr">3</xref>). Emerging data clearly illustrate that vaccines drive protection <italic toggle="yes">via</italic> mechanistically distinct antibody functions including (i) neutralization, (ii) opsonophagocytosis, (iii) cytokine secretion, (iv) inflammatory cell degranulation, and (v) complement deposition and several others. For example, neutralizing antibodies are crucial for protection against measles (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>), opsonophagocytic antibodies are key to defense against <italic toggle="yes">Streptococcus pneumoniae</italic> (<xref rid="B6" ref-type="bibr">6</xref>), and antibodies able to drive cytotoxic destruction of infected cells are linked to immunity against influenza (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>). It is important to note that these functions frequently synergize with each other to confer protection, and analysis of one function alone is likely not sufficient to account for the entirety of &#8220;protective immunity.&#8221; Recently developed sophisticated functional immune assays that investigate antibody mechanism of action represent a more pivotal readout of immunity and marker of true clinical efficacy. This review aims to review antibody mechanisms of protection across pathogens, explore the mechanisms by which these antibody functions are driven selectively by the immune system, and discuss novel strategies to harness these functions for future vaccine development.</p></sec><sec id="s2"><title>MECHANISMS OF ANTIBODY-MEDIATED PROTECTION</title><p>Antibodies recognize pathogens through their antigen-binding fragments (Fab). Each human immunoglobulin is composed of two Fab domains and a constant crystallizable fragment (Fc fragment) domain. The Fab fragments are composed of a heterodimer of a light chain (LC) and a heavy chain (HC). The Fc-domain is composed of HC only and linked to the Fab <italic toggle="yes">via</italic> a hinge region (<xref rid="F1" ref-type="fig">Fig. 1A</xref>) (<xref rid="B9" ref-type="bibr">9</xref>). The Fc domain interacts with effector cells <italic toggle="yes">via</italic> their Fc-receptors (FcR) and/or complement receptors (<xref rid="F1" ref-type="fig">Fig. 1B</xref>). The Fc domain binds to specialized cell-surfaced and secreted receptors, including FcR, complement, and other non-canonical receptors found on immune cells (<xref rid="B10" ref-type="bibr">10</xref>). Thus, the Fab provides antigen specificity, tethering the antibody to the pathogen or pathogen-associated peptides, whereas the Fc links the adaptive (Fab) and innate (FcR) immune systems.</p><fig position="float" fig-type="figure" id="F1" orientation="portrait"><label>Fig 1</label><caption><p>IgG structure and Fc-mediated effector mechanisms and antibody glycosylation. (<bold>A</bold>) An IgG consists of two fragments, an antigen-binding fragment (Fab) and a crystallizable fragment (Fc) connected by a flexible hinge region. The Fab region includes variable and constant domains both on the heavy (VH and VL) and light chains (CL and CH1). The Fc fragment contains complementary CH2 and CH3 domains with an N-linked glycan attached to a conserved glycosylation site at Asn297 of the CH2 (simplified picture). (<bold>B</bold>) Antibodies recognize and bind to pathogens <italic toggle="yes">via</italic> the Fab fragment. The Fc-region, then, interacts with Fc-receptors (FcRs) present in various types of immune cells. (<bold>C</bold>) Antibody subclasses and isotypes bind to FcRs with different affinities and are differentially expressed across various cell types. (<bold>D</bold>) The structure of the biantennary N-linked glycan, attached to asparagine 297 of the IgG heavy chain constant domain (CH2), sits between the arms of the Fc and regulates antibody function by altering the structure of the Fc. Changes in the shape and flexibility of the Fc alter the affinity of the Fc for Fc receptors. The core glycan comprises of two consecutive <italic toggle="yes">N</italic>-acetylglucosamine (GlcNAc) molecules, followed by a mannose and two additional mannose antennae, each with a single GlcNAc attached. In addition, four sugars can be added in variable combinations. Two galactoses can be added to the antennary GlcNAcs (galactosylation), followed by sialic acid that can be added to each of the galactose residues (sialylation). In addition, a single GlcNAc can be added to the core mannose, creating a bisecting arm (bisection). Finally, fucose can be added to the first GlcNAc (fucosylation).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="mbio.03036-23.f001.jpg"/></fig><p>The Fc-domain is a multifaceted linker, providing specific instructions to the innate immune system on how it should process the target to which the antibody binds. FcRs recognize the Fc regions of IgG antibodies and include Fc-gamma receptor I (Fc&#947;RI, also known as CD64), Fc&#947;RII (also known as CD32), and Fc&#947;RIII (also known as CD16). These will be referred to as Fc&#947;R throughout this review. Additional FcRs exist for other antibody isotypes including Fc&#1013;RI:IgE, Fc&#945;RI/CD89:IgA, Fc&#956;R:IgM, and Fc&#945;/&#956;R:IgA/IgM (<xref rid="B11" ref-type="bibr">11</xref>). The wide array of FcRs provides a critical mechanism for antibodies of distinct isotypes to interact with and activate signaling cascades of numerous cells of the immune system upon pathogen recognition.</p><p>IgG can also bind to non-canonical receptors such as the neonatal Fc receptor (FcRn). FcRn binds the Fc-domain of IgG with high affinity at low pH, allowing for efficient capture and release of antibodies across cell barriers. This mechanism also plays an essential role in serum IgG homeostasis. In addition to their role in trafficking IgG1, FcRn is expressed on multiple immune cells, such as dendritic cells (DCs), macrophages, monocytes, neutrophils, and B cells, to facilitate the uptake and degradation of IgG-opsonized pathogens. For example, the association of hemaglutinin (HA) head-specific antibody-viral complexes with FcRn prevents viral ribonucleoprotein transport to the nucleus, preventing virus replication (<xref rid="B12" ref-type="bibr">12</xref>). In addition to FcRs, complement receptors (CRs) expressed by antigen-presenting cells (APCs) are essential for mediating effector function. Complement proteins C3b and C4b, deposited on immune complexes following C1q engagement, can bind to the transmembrane CR1 found on innate immune cells such as neutrophils, monocytes, and dendritic cells. The binding of the C3b-immune complex to membrane CR1 on antigen-presenting cells induces opsonization and antigen presentation in the context of major histocompatibility complex (MHC) molecules to enhance T-cell immunity (<xref rid="B13" ref-type="bibr">13</xref>). In addition, C3b, as well as other derivatives iC3b, C3dg, and C3d, bind to the B-cell receptors CR2 and CR1 and play a key role in enhancing B-cell immunity by increasing their entrance and survival in germinal centers (GCs) as well as stimulating memory B-cell development (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>).</p><p>FcRs are expressed in diverse combinations on different cell types, which leads to unique response patterns. The majority of innate effector cells (monocytes, macrophages, DCs, basophils, and mast cells) co-express both activating FcRs (Fc&#947;RI, Fc&#947;RIIa, and Fc&#947;RIIIa) and inhibitory FcR (Fc&#947;RIIb). This allows for the balancing of Ig-mediated cellular activation (<xref rid="B16" ref-type="bibr">16</xref>). Fc&#947;RI binds to IgG much more potently than other receptors. Fc&#947;RII and Fc&#947;RIII are characterized by a low affinity for IgG (with K<sub>D</sub> for human IgG1 = 10<sup>&#8722;5</sup>&#8211;10<sup>&#8722;7</sup>M) and are also able to engage multimeric immune complexes (IgG-antigen complexes) through high avidity interactions (<xref rid="B17" ref-type="bibr">17</xref>).</p><p>Antibody isotype/subclass selection and glycosylation collectively shape the binding affinity of antibodies to FcRs and complement. Following initial antigen recognition, either infection or immunization, affinity maturation of the Fab and class switch recombination (CSR) of the Fc lead to the production of higher affinity IgGs of different subclass/isotypes (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>). The process leads to the directed combination of particular antigen specificities with unique functions <italic toggle="yes">via</italic> the maintenance or replacement of the Ig heavy chain (HC) with one of 10 distinct constant regions [e.g., C&#956; (IgM), C&#947; (IgG1-4), C&#945; (IgA1 or 2), or C&#949; (IgE)] each with a unique affinity for Fc-receptors and complement (<xref rid="B20" ref-type="bibr">20</xref>). Humans possess four IgG subclasses (IgG1, IgG2, IgG3, and IgG4) with different functionality and affinity for Fc&#947;Rs (<xref rid="B21" ref-type="bibr">21</xref>). IgG subclasses demonstrate different affinities for Fc&#947;Rs, with IgG3 having the highest affinity for most Fc&#947;Rs, followed by IgG1, IgG4, and IgG2 (<xref rid="F1" ref-type="fig">Fig. 1C</xref>) (<xref rid="B22" ref-type="bibr">22</xref>).</p><p>In addition to isotype and subclass selection, changes in Fc-glycosylation at conserved sites on the antibody-heavy chain profoundly alter antibody interactions with FcRs (<xref rid="F1" ref-type="fig">Fig. 1D</xref>). For example, when the N-glycan is enzymatically cleaved from IgG, the antibody&#8217;s ability to bind to Fc&#947;Rs is abrogated (<xref rid="B23" ref-type="bibr">23</xref>). Given the importance of IgG Fc-glycosylation on shaping Fc&#947;R binding, specific Fc-glycan structures have been linked to distinct Fc-effector functions. Along these lines, a loss of fucosylation (afucosylation) improves IgG affinity for Fc&#947;RIIIa (<xref rid="B24" ref-type="bibr">24</xref>). In addition, increased sialylation has been linked to anti-inflammatory functions (<xref rid="B25" ref-type="bibr">25</xref>).</p><p>Shifts in glycosylation patterns have been documented in different pathological and physiological conditions such as between autoimmune and infectious diseases, as well as age, vaccination, and pregnancy. Specifically, reproducible shifts toward enhanced agalactosylated antibodies emerge under chronic inflammatory conditions and a rapid loss of galactose on disease-specific antibodies precedes the onset of autoimmune flares (<xref rid="B26" ref-type="bibr">26</xref>). After vaccination, antigen-specific antibody populations are decorated with different Fc-glycans (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>). Moreover, these glycans shift in a pathogen-specific manner (<xref rid="B29" ref-type="bibr">29</xref>). Similarly, glycan signatures can shift depending on a vaccine adjuvant, even if the vaccine is targeted to the same antigen (<xref rid="B29" ref-type="bibr">29</xref>). These data collectively suggest that antibody glycosylation is a highly regulated process (<xref rid="B30" ref-type="bibr">30</xref>). Intracellularly, a complex cascade of glycosyltransferases and glycosidases acts to shape the Fc-glycan in a sequential and highly organized manner in the Golgi apparatus. Analysis of the sialyltransferase St6Gal1 and the fucosyltransferase Fut8 expression in plasmablasts and memory B cells at different time points following trivalent influenza virus vaccination has demonstrated significant shifts in enzyme expression, likely to be key to shaping the antibody glycans (<xref rid="B31" ref-type="bibr">31</xref>). Along these lines, alterations in Fc glycoforms on HA-specific IgGs have been directly linked to glycosyltransferase expression profiles (<xref rid="B30" ref-type="bibr">30</xref>).</p><p>The Fab represents an evolutionary marvel, permitted to evolve genetically, <italic toggle="yes">via</italic> somatic hypermutation, to explore a nearly infinite number of sequence-based solutions to develop ultra-specific binding to an antigen. This process of evolution and integrated perpetual selection within the germinal center (GC) of the lymph node enables the selection of antibodies to mount a multipronged targeting program to a pathogen at distinct regions of interest. The ability of B cells to create this diversified repertoire of binding antibodies is owed to their somatic hypermutation (SHM) through mechanisms such as activation-induced cytidine deaminase (AID). Cytidine deamination converts the nucleotide to uracil, which can result in (1) C &#8594; T mutation during replication as uracil will be read as thymine by DNA polymerase; (2) activation of the double-strand break repair pathway and translesion DNA synthesis, resulting in mutations at the C or neighboring nucleotides; and (3) non-canonical mismatch repair pathway activation in which the highly mutagenic DNA polymerase &#951; is recruited to the G:U mismatch (<xref rid="B32" ref-type="bibr">32</xref><xref rid="B33" ref-type="bibr">&#8211;</xref><xref rid="B35" ref-type="bibr">35</xref>). This entire mutagenic process occurs largely within the variable (<italic toggle="yes">v</italic>) and diversity (<italic toggle="yes">d</italic>) gene segments of the immunoglobulin loci within B cells (<xref rid="B36" ref-type="bibr">36</xref><xref rid="B37" ref-type="bibr">&#8211;</xref><xref rid="B38" ref-type="bibr">38</xref>). The hotspots of these mutations within the <italic toggle="yes">v</italic> and <italic toggle="yes">d</italic> gene segments correspond to the complementarity-determining regions (CDR). These CDRs, located on the heavy chain of the immunoglobulin, are responsible for the direct contact of the Fab with the antigen (<xref rid="B39" ref-type="bibr">39</xref><xref rid="B40" ref-type="bibr">&#8211;</xref><xref rid="B41" ref-type="bibr">41</xref>). Therefore this deliberate, gene-segment localized mutagenic process can give rise to a bevy of unique antibody-producing B cells. Immunoglobulins produced by B cells that exhibit low affinity to the target antigen undergo apoptosis whereas B cells producing antibodies of strong antigen binding potential are expanded (<xref rid="B42" ref-type="bibr">42</xref>). <italic toggle="yes">Via</italic> this process, the immune system is progressively populated by waves of antibodies that evolve to bind more rapidly, more specifically, and with higher affinity to target antigens of interest with a diversity of functions.</p><p>A notable class of antibodies are those that specifically recognize regions of pathogens used to mediate penetrance. These &#8220;neutralizing antibodies&#8221; selectively displace or interfere with pathogen-antigen binding with stunning precision. For example, neutralizing antibodies to HIV and Dengue virus must bind to specific minimal, often quaternary epitopes, on virion glycoproteins to drive neutralization (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>). Similarly, antibodies able to block and displace bacterial toxins, such as those produced by <italic toggle="yes">Corynebacterium diphtheriae</italic> and <italic toggle="yes">Bacillus anthracis</italic>, are also key to vaccine-mediated protection (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>). Increasing evidence, however, has illustrated that blocking a toxin or pathogen from accessing entry receptors cannot completely ablate disease. Data increasingly point to the important role of Fc-mediated recruitment of innate immune effector functions in the clearance of toxins and pathogens. For some neutralizing antibodies against viruses, such as HIV, Fc-mediated functions are also essential for protection <italic toggle="yes">in vivo</italic>. In this case, protective activity can be lost if antibody-mediated interactions with FcRs are abrogated (<xref rid="B47" ref-type="bibr">47</xref>). Therefore, there exists an intimate collaboration between the Fab and the Fc for protection.</p><p>While neutralization is critical for protection against several infections, neutralization is not necessary against all infections (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B49" ref-type="bibr">49</xref>). For example, in the case of influenza, some antibodies to the stem of the hemagglutinin (HA) antigen, involved in binding and infection, do not neutralize the virus <italic toggle="yes">in vitro</italic>. However, these antibodies can block infection <italic toggle="yes">in vivo</italic> (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>). Interestingly, the protective activity of these antibodies depends on the ability of the antibodies to interact with FcRs and appears to depend on the selective recruitment of NK cells to exert antibody-dependent cellular cytotoxicity (ADCC) (<xref rid="B52" ref-type="bibr">52</xref>). Moreover, population-level studies have also demonstrated increased levels of antibody-dependent complement deposition (ADCD), and antibody-dependent cellular phagocytosis (ADCP) by myeloid-lineage cells and neutrophils in cohorts of individuals that exhibit a reduced likelihood of infection (<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B53" ref-type="bibr">53</xref>).</p><sec id="s2-1"><title>Antibody-dependent cellular phagocytosis</title><p>ADCP is the humoral immune function whereby antibody-opsonized pathogens or infected cells bind to FcRs or complement on the surface of phagocytes to drive immune complex uptake (<xref rid="F2" ref-type="fig">Fig. 2A</xref>). Professional phagocytes include monocytes, macrophages, neutrophils, DCs, or eosinophils, all of which express different combinations of FcRs, including FcRs for all antibody isotypes. However, FcR expression varies on these cells in a tissue-dependent manner, where mucosal macrophages and DCs express high levels of Fc&#945;RI (CD89), not found on peripheral macrophages and DCs, enabling these cells to respond to antibody-opsonized material in a tissue-specific manner.</p><fig position="float" fig-type="figure" id="F2" orientation="portrait"><label>Fig 2</label><caption><p>The impact of different routes of vaccination and formulation on Fc-mediated antibody effector functions. (<bold>A</bold>) ADCP, ADCC, and antibody-dependent complement activation are the main Fc-receptor-mediated antibody effector functions leading to the destruction and clearance of the pathogen and therefore protection against infection/disease. Binding of the pathogen-specific antibodies to the surface of the pathogen leads to the formation of immune complexes. The interaction of the Fc-domain of antibodies from immune complexes and Fc-receptors present on multiple types of innate immune cells mediates the downstream effector functions. (<bold>B</bold>) Different routes of immunization, such as intravenous (IV), intradermal (ID), intramuscular (IM), and mucosal, enable to target distinct types of APCs leading to the production of particular cytokines further shaping the antibody type and their Fc-effector functions as well as proper choice of a delivery system and adjuvant initiate distinct early immune response at the site of vaccine administration and therefore influence the Fc-subclass/Fc-glycosylation selection (<bold>C</bold>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="mbio.03036-23.f002.jpg"/></fig><p>The early steps of ADCP depend on the number and combination of FcRs engaged (relative to the ligand and antibody density on the target antigen). The binding of activating classical FcRs leads to the phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAM) (on activating FcRs) and initiation of signaling cascades (<xref rid="B54" ref-type="bibr">54</xref>). Given the higher affinity of IgG1 and IgG3 for Fc&#947;R binding, immune complexes composed of these antibodies lead to rapid triggering and robust phagocytic clearance of these antibody complexes. In addition, IgA and IgM have also been implicated in rapid and robust immune complex uptake, triggered by both isotype-specific Fc-receptors and complement receptors.</p><p>Depending on the immune cell triggered, different inflammatory responses may evolve following phagocytosis. In human blood, neutrophils are a critical first line of defense against pathogens. Due to their unique FcR repertoire, including Fc&#947;RIIa (CD32a), Fc&#947;RIIIb (CD16b), Fc&#947;RI (CD64), and Fc&#945;RI (CD89), these innate immune cells represent highly specialized gatekeepers able to rapidly respond to antibody-complexes, drive rapid degradation and clearance, and support antigen cross-presentation (<xref rid="B55" ref-type="bibr">55</xref>). However, depending on the FcRs triggered, distinct inflammatory consequences can evolve. For example, IgA/Fc&#945;RI binding can lead to rapid neutrophil extracellular trap formation, or NETosis killing (<xref rid="B56" ref-type="bibr">56</xref>). Conversely, IgG activation of neutrophils can lead to degranulation and cytokine secretion. DCs, on the other hand, pick up antibody complexes, and depending on the antibody/FcR binding profiles, can lead to lysosomal proteolytic degradation and/or antigen presentation through MHCI and MHCII. This simultaneously allows for a response to existing pathogens and a priming of new memory responses (<xref rid="B57" ref-type="bibr">57</xref>). This DC switch is regulated by antibody-binding to the neonatal Fc-receptor, FcRn, which drives uptake in a pH-dependent manner.</p><p>Beyond FcRs, immune complex uptake may also occur following complement deposition on immune complexes. In addition to their role in creating pores in membranes, the complement components deposited on immune complexes interact with complement receptors (CR) found in phagocytic immune cells. For example, the first component of the classical complement cascade, C1q, interacts with the C1q-receptor (C1qr) found in myeloid cells (<xref rid="B58" ref-type="bibr">58</xref>). In addition, following the activation of C3 and deposition of C3b, iC3b (after cleavage of C3b), and C3d on immune complexes, complement receptors (CRs) can mediate phagocytosis. These receptors include CRIg, the multifunctional CR1, CR2, and the &#946;2-integrin members CR3 and CR4. Surface expression of these complement receptors differs, with CR1 and CR2 being expressed on myeloid, neutrophils B cells, and macrophages, CR3 and CR4 being present on myeloid, neutrophils, activated lymphocytes, and natural killer cells, and CRIg being present on tissue-specific macrophages (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B59" ref-type="bibr">59</xref><xref rid="B60" ref-type="bibr">&#8211;</xref><xref rid="B68" ref-type="bibr">68</xref>). Complement-mediated phagocytosis is particularly essential during the acute immune response to infection, where low-affinity IgMs efficiently recruit C1q and drive rapid and effective phagocytic clearance. In addition, this IgM/C1q phagocytic axis also plays a critical response in protection against T-cell-independent antigens. Moreover, because T cells also express C3aR, C5aR1, and C5aR2, adaptive immune cells may also be activated by antibody complexes, resulting in broader immune activation (<xref rid="B69" ref-type="bibr">69</xref><xref rid="B70" ref-type="bibr">&#8211;</xref><xref rid="B72" ref-type="bibr">72</xref>). Given the extensive expression of CRs, these receptors likely collaborate with FcRs to drive clearance, intracellular routing, and immune activation/signaling to nearby cells.</p><p>ADCP has been implicated in the protection against bacteria (<xref rid="B73" ref-type="bibr">73</xref>), parasites (<xref rid="B61" ref-type="bibr">61</xref>), fungi (<xref rid="B74" ref-type="bibr">74</xref>), and viruses (<xref rid="B75" ref-type="bibr">75</xref>). Opsonophagocytosis plays an important protective role against <italic toggle="yes">Streptococcus pneumoniae</italic>, <italic toggle="yes">Staphylococcus aureus</italic>, <italic toggle="yes">Pseudomonas aeruginosa,</italic> and <italic toggle="yes">Klebsiella pneumoniae</italic>. Surface-exposed proteins and cell wall components are targets for antibodies able to interact with Fc&#947;Rs and CRs, leading to rapid bacterial uptake and destruction. For example, meningococcal-specific polysaccharide-specific IgG2 that interacts with Fc&#947;RIIa leads to increased killing <italic toggle="yes">via</italic> neutrophils (<xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B76" ref-type="bibr">76</xref>). Similarly, neutrophil-mediated opsonophagocytic killing plays a critical role in immunity against fungal <italic toggle="yes">Candida albicans</italic> infection (<xref rid="B77" ref-type="bibr">77</xref>), shown recently to be critical in the defense against multidrug-resistant fungal pathogens (<xref rid="B74" ref-type="bibr">74</xref>).</p><p>Recent evidence points to a critical role for opsonophagocytosis in antiviral and anti-parasitic immunity. For example, vaccine-induced antibody-mediated phagocytosis has been linked to protection against the simian immunodeficiency virus (SIV), the evolutionary precursor of HIV (<xref rid="B78" ref-type="bibr">78</xref>). Interestingly, using the same DNA/Adenoviral-based SIV vaccine, monocyte recruiting IgG phagocytic responses were induced by intra-muscular vaccination, whereas IgA-driven neutrophil phagocytic responses were induced by intranasal immunization, both resulting in ~50% protection from infection. Given the presence of higher levels of phagocytic antibodies among human spontaneous controllers of HIV infection (<xref rid="B79" ref-type="bibr">79</xref>) and our emerging appreciation for the role of homozygosity for the low-affinity Fc&#947;RIIa allele among HIV rapid progressors (defined by a low CD4<sup>+</sup> T-cell count) (<xref rid="B80" ref-type="bibr">80</xref>), these data highlight the role of opsinophagocytosis in HIV control. Moreover, the data point to opportunities to drive distinct phagocytic responses, <italic toggle="yes">via</italic> monocytes or neutrophils, by vaccination route.</p><p>Phagocytic responses by neutrophils were linked with long-term vaccine-mediated protection against Ebolavirus (EBOV) in non-human primates (<xref rid="B81" ref-type="bibr">81</xref>). Interestingly, phagocytic responses correlated with survival post-virus challenge were against the truncated EBOV glycoprotein (GP), termed the soluble GP (or sGP) (<xref rid="B81" ref-type="bibr">81</xref><xref rid="B82" ref-type="bibr">&#8211;</xref><xref rid="B83" ref-type="bibr">83</xref>). These functionally leveraged antibodies were more clear correlates of protection than neutralizing antibodies themselves. The vaccine platform was a live-attenuated vesicular stomatitis virus that encodes for EBOV GP, administered intramuscularly (<xref rid="B84" ref-type="bibr">84</xref>). This again hints at vaccination platform-based and/or immunization sites as key determinants of antibody functions (see section Prospects for Fc programming).</p><p>The COVID-19 pandemic provided unprecedented insight into how ADCP functions as a novel pathogen. Humoral immunity was low in the human population prior to 2019, allowing for the generation of a novel, polyfunctional antibody response through vaccination and/or recovery. The primary target of SARS-CoV-2-directed antibodies is the spike glycoprotein. ADCP of the spike is mediated through antibodies recognizing the viral protein at multiple subdomains (<xref rid="B85" ref-type="bibr">85</xref><xref rid="B86" ref-type="bibr">&#8211;</xref><xref rid="B90" ref-type="bibr">90</xref>), whereas neutralizing antibodies are much more specifically targeted to the receptor binding domain. The presence of ADCP-leveraged antibodies is linked to positive clinical outcomes and protection against antigenically drifted SARS-CoV-2 variants (<xref rid="B85" ref-type="bibr">85</xref>, <xref rid="B86" ref-type="bibr">86</xref>, <xref rid="B91" ref-type="bibr">91</xref>).</p><p>Similarly, vaccine-induced phagocytic antibodies against malaria have been implicated in the protection against parasitic infection (<xref rid="B92" ref-type="bibr">92</xref>). Recent immune correlates analysis of the most advanced malaria vaccine candidate, RTS&#8217;S (<xref rid="B93" ref-type="bibr">93</xref>, <xref rid="B94" ref-type="bibr">94</xref>), have pointed to a critical role for phagocytosis as a key mechanism of protection following vaccination (<xref rid="B92" ref-type="bibr">92</xref>). While decades of data had clearly linked protection from infection following vaccination to vaccine-induced titers, functional characterization of these antibodies pointed to an enrichment of phagocytic functions in individuals able to resist the <italic toggle="yes">Plasmodium</italic> challenge (<xref rid="B93" ref-type="bibr">93</xref>).</p><p>Given the abundance of phagocytic cells in the skin, blood, and liver, it remains unclear where this protective activity may occur on a pathogen-by-pathogen basis. For example, the presence of spike-reactive IgG1 in the lungs was a correlate of protection for COVID-19 but compartment-specific functions of ADCP have not yet been delineated for COVID-19. This is also true for <italic toggle="yes">Plasmodium</italic>, which has a multi-compartment life cycle. Future studies into how ADCP is regionally activated are warranted.</p></sec><sec id="s2-2"><title>Antibody-dependent cellular cytotoxicity</title><p>ADCC represents the mechanism by which innate effector cells (lacking specificity for an antigen) recognize antibody-opsonized pathogens/antigens, or entire infected cells, and trigger the cytotoxic destruction of that antibody-opsonized target (<xref rid="F2" ref-type="fig">Fig. 2A</xref>). Cytotoxicity is driven by the release of cytotoxic granules containing perforins and granzymes from cytotoxic effector cells. ADCC is best described for IgG-mediated natural killer cell (NK) activation. Specifically, IgG1 and IgG3 appear to drive ADCC most effectively due to their affinity for Fc&#947;RIIIa (CD16), a dominant Fc&#947;R found in NK cells. However, the engagement of Fc&#947;RI (CD64) and Fc&#947;RII (CD32) has also been implicated in macrophage-, neutrophil-, or eosinophil-mediated degranulation and cytotoxicity (<xref rid="B16" ref-type="bibr">16</xref>). Furthermore, emerging data point to a role for IgA-Fc&#945;R and IgE-Fc&#949;R as additional mediators of ADCC by neutrophils, particularly in the setting of cancer treatments (<xref rid="B95" ref-type="bibr">95</xref>, <xref rid="B96" ref-type="bibr">96</xref>). ADCC-like activities can also occur in cytolytic granule-producing neutrophils, monocytes, macrophages, basophils, eosinophils, NK T cells, &#945;&#946;, and &#947;&#948; CD8+ T cells, <italic toggle="yes">via</italic> Fc-mediated activation (<xref rid="B97" ref-type="bibr">97</xref>). The distinct granule contents found in each of these cell types can result in a remarkable breadth of distinct inflammatory and cytotoxic outcomes.</p><p>ADCC has been implicated in protection against multiple viruses and some intracellular bacteria and parasites. ADCC can act both indirectly to eliminate the pathogen within infected cells as well as directly on particular pathogens. For example, ADCC activity has been linked to disease control following HIV, influenza virus, Ebolavirus, or respiratory syncytial virus (RSV) challenge(s). Several studies have noted enhanced ADCC-inducing antibodies among HIV spontaneous controllers compared to individuals progressing to AIDS (<xref rid="B98" ref-type="bibr">98</xref>). Similarly, both animal and human studies have demonstrated a critical role for ADCC in the control of influenza, where survival and recovery following H7N9 infection were preferentially observed in the presence of anti-HA antibodies able to activate primary NK cells (<xref rid="B99" ref-type="bibr">99</xref>). Conversely, non-survivors of both HIV and influenza infections generate lower levels of Fc&#947;R binding antibodies and reduced ADCC (<xref rid="B99" ref-type="bibr">99</xref>). Along the same lines, reduced NK cell counts have been observed in hospitalized children with RSV lower respiratory infection (<xref rid="B100" ref-type="bibr">100</xref>). Moreover, NK cell-activating monoclonal antibodies have been shown to provide enhanced protection against Ebolavirus, particularly for antibodies targeting the base of GP (<xref rid="B101" ref-type="bibr">101</xref>). For COVID-19, the kinetics of Fc&#947;RIIIa-binding antibodies were linked to severe disease survival (<xref rid="B91" ref-type="bibr">91</xref>). Finally, as mentioned above, cross-influenza protective antibodies that target the HA-stem, which is more conserved across influenza viruses, utilize ADCC-like activities for protection (<xref rid="B102" ref-type="bibr">102</xref>). Collectively, the ability to recruit NK cells appears key to protection against a variety of viruses.</p><p>Interestingly, ADCC has also been implicated in protection against intracellular bacteria as well as some parasites. Because cytotoxic granules must fuse with the target membrane and release granzymes into the cell to drive destruction, canonical ADCC activity is not compatible with all pathogen membranes. For example, NK cells may have a limited capacity to eliminate highly coated bacteria, but emerging data point to a critical role for NK cells in the destruction of intracellular bacteria once inside monocytes/macrophages. Specifically, both elevated levels of FcR-expressing NK cells (<xref rid="B103" ref-type="bibr">103</xref>) and enhanced ADCC-inducing antibodies have been observed in controlled <italic toggle="yes">Mycobacterium tuberculosis</italic> (Mtb) infection compared to individuals with active, uncontrolled disease (<xref rid="B104" ref-type="bibr">104</xref>). Likewise, NK cells have been implicated in the control of parasite infections such as malaria and trypanosomiasis. For <italic toggle="yes">Plasmodium</italic>, NK cells have been implicated in killing the parasite during the blood stage by attacking infected red blood cells (<xref rid="B105" ref-type="bibr">105</xref>) and eliminating the liver stage of the infection <italic toggle="yes">via</italic> the killing of infected hepatocytes (<xref rid="B106" ref-type="bibr">106</xref>). Similarly, ADCC has been implicated in the direct elimination of <italic toggle="yes">Trypanosoma cruzi</italic> (<xref rid="B107" ref-type="bibr">107</xref>), mechanistically pointing to FcR&#947;IIIa-dependent ADCC activity as a key mechanism for the direct elimination of these pathogens.</p></sec><sec id="s2-3"><title>Antibody-dependent complement activation</title><p>In addition to the directed role of innate immune cells, antibodies can also recruit the complement cascade to destroy pathogens. Complement is a complex of soluble blood proteins that can be deposited to mark antibody complexes for destruction. Complement is an evolutionarily conserved process that represents one of the first lines of innate immune defense against many bacteria, yeasts, and viruses. Activation of the complement cascade can lead to direct or indirect destruction of pathogens through (i) the formation of a self-organized membrane attack complex (MAC) on the surface of the pathogen membrane, (ii) directed pathogen uptake, or (iii) the activation of the innate immune system by inflammatory mediators (<xref rid="F2" ref-type="fig">Fig. 2A</xref>).</p><p>IgM, followed by IgG3 and IgG1, display the highest potential to activate the classical complement pathway. This pathway is triggered by IgM deposition on a target antigen or the formation of IgG hexamers, either of which allows C1q to bind (<xref rid="B63" ref-type="bibr">63</xref>). This initial binding of C1q to surface-bound IgM or IgG results in the autoactivation of C1r and cleavage of C1s. Active C1s cleave C4 and C2, which collectively form the C3 convertase, C4bC2a. The C3 convertase cleaves C3, the major complement protein in serum. Upon cleavage, C3a (an anaphylatoxin) is released, and C3b (the opsonizing agent and ligand for complement receptors) deposits on the surface of the antibody target (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B108" ref-type="bibr">108</xref>). Complement activation can drive phagocytic uptake or can continue to catalyze the deposition of complement components, leading to the formation of the MAC. The formation of the MAC is blocked on the surface of most human cells by MAC-disassembling mechanisms aimed at preventing non-specific cellular destruction (<xref rid="B108" ref-type="bibr">108</xref>). Most pathogens lack these factors, providing an opportunity for the complement to act in pathogen destruction. Interestingly, many enveloped viruses, including HIV, human cytomegalovirus, hepatitis C, and vaccinia virus (<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B109" ref-type="bibr">109</xref>, <xref rid="B110" ref-type="bibr">110</xref>), steal human complement decay activating factor (DAF/CD55) on their viral membranes, allowing them to subvert complement-mediated destruction. However, because C1q aggregates antibodies, complement can enhance viral neutralization by blocking and clustering viral receptors (<xref rid="B111" ref-type="bibr">111</xref>) as well as direct viruses to opsonophagocytic uptake.</p><p>Complement is essential in the control of multiple bacterial infections, as observed in individuals with complement deficiencies, who experience higher rates of recurrent encapsulated bacterial infections such as <italic toggle="yes">Streptococcus pneumoniae</italic>, <italic toggle="yes">Haemophilus influenzae</italic>, and <italic toggle="yes">Neisseria meningitidis</italic>, especially in early childhood (<xref rid="B112" ref-type="bibr">112</xref>). Moreover, complement is key to protection against enteric pathogens including <italic toggle="yes">Salmonella typhimurium</italic> and <italic toggle="yes">Shigella</italic> (<xref rid="B113" ref-type="bibr">113</xref>) as individuals with high levels of SBA-inducing antibodies exhibited reduced disease.</p><p>In the context of viral pathogens, a study conducted in complement-deficient mice (a classical pathway C1q<sup>&#8722;/&#8722;</sup>, a lectin pathway C4<sup>&#8722;/&#8722;</sup>, an alternative pathway factor D (fD)<sup>&#8722;/&#8722;</sup>, and factor B (fB)<sup>&#8722;/&#8722;</sup>) demonstrate that all complement activation pathways are essential for control of severe West Nile Virus disease (<xref rid="B114" ref-type="bibr">114</xref>). Similarly, complement-mediated viral lysis was observed against HIV in patients with acute HIV infection (<xref rid="B115" ref-type="bibr">115</xref>). Complement also plays a key role in vaccinia virus (VACV) neutralization, highlighting the collaboration between the Fab and the Fc in antibody-mediated protection against VACV (protection confirmed in mouse models of VACV infection) (<xref rid="B116" ref-type="bibr">116</xref>). Thus, both direct complement-mediated killing and indirect complement-mediated phagocytic clearance of pathogens are key to protection against pathogens.</p></sec></sec><sec id="s3"><title>PROSPECTS FOR FC PROGRAMMING</title><p>Given our mounting appreciation for the role of diverse humoral immune functions in the control and elimination of multiple pathogens, defining novel mechanisms to control and tune both Fab-evolution and Fc-effector function may offer novel opportunities to strategically design more effective vaccines. Distinct delivery platforms and adjuvants have been shown to elicit unique Fc-effector function signatures, even when directed toward the same antigen (<xref rid="B117" ref-type="bibr">117</xref><xref rid="B118" ref-type="bibr">&#8211;</xref><xref rid="B119" ref-type="bibr">119</xref>). Several approaches exist to tune early inflammatory cues to shape and direct the vaccine-induced humoral immune response (<xref rid="F2" ref-type="fig">Fig. 2B</xref>).</p><sec id="s3-1"><title>Route of vaccination</title><p>The route of vaccination and the initial types of innate immune cells triggered can dramatically alter the quality of the humoral immune response. Specifically, different innate immune APCs exist within different tissues, programmed to drive tissue-appropriate immunity (<xref rid="B120" ref-type="bibr">120</xref>, <xref rid="B121" ref-type="bibr">121</xref>). Given that APCs are loaded with diverse sets of pattern recognition receptors expressed in a tissue-specific manner, APCs can rapidly respond to new antigens. This local and APC-specific activation drives downstream inflammatory responses that shape the adaptive immune response (<xref rid="F2" ref-type="fig">Fig. 2B</xref>). For example, vaccines delivered mucosally target mucosal resident APCs poised to elicit mucosal-centric immunity, including the induction of higher levels of IgA (<xref rid="B122" ref-type="bibr">122</xref>). Intramuscular (IM) vaccination results in the recruitment of DCs that drive a systemic-centric immune response, largely populated by IgG. The skin is highly enriched in multiple subsets of professional APCs including Langerhans cells, dermal dendritic cells (dDCs), and macrophages, and thus can respond aggressively to novel antigens (<xref rid="B123" ref-type="bibr">123</xref>). Along these lines, multiple studies have posited that intradermal delivery of influenza vaccines results in improved immunogenicity and more durable immune responses than the typical IM route (<xref rid="B124" ref-type="bibr">124</xref><xref rid="B125" ref-type="bibr">&#8211;</xref><xref rid="B127" ref-type="bibr">127</xref>). Also, intravenous vaccination approaches against malaria (<xref rid="B128" ref-type="bibr">128</xref>) and <italic toggle="yes">Mycobacterium tuberculosis</italic> (<xref rid="B129" ref-type="bibr">129</xref>) showed strong protection related to the induction of enhanced tissue-resident immunity within the liver and lung, respectively.</p><p>The IM route of vaccination can stimulate highly functional IgG responses. This is true for a variety of platforms including mRNA (<xref rid="B87" ref-type="bibr">87</xref>, <xref rid="B130" ref-type="bibr">130</xref>, <xref rid="B131" ref-type="bibr">131</xref>), live-attenuated (<xref rid="B132" ref-type="bibr">132</xref>), inactivated (<xref rid="B133" ref-type="bibr">133</xref>), and component-based vaccines (<xref rid="B134" ref-type="bibr">134</xref>). These functions include the Fc&#947;R-leveraged functions such as ADCP (both myeloid-lineage and neutrophil), ADNK, and ADCD. Interestingly, stimulation of Fc-effector functions through IM vaccination appears to also be bolstered through localized inflammation induced by adjuvants (<xref rid="B134" ref-type="bibr">134</xref>, <xref rid="B135" ref-type="bibr">135</xref>). Intranasal (IN) route of vaccination has also been shown to stimulate a durable humoral response, including antibody effector functions. In a study comparing IM and IN vaccination, ADCP by neutrophils was significantly higher in IN-delivered vaccinations, while ADCP driven by monocytes was similar between IM and IN vaccination groups (<xref rid="B136" ref-type="bibr">136</xref>). Thus, the route of delivery can result in unique antibody programming and can elicit more tissue/compartment targeted protection.</p></sec><sec id="s3-2"><title>Adjuvants</title><p>While the route can shape the localization of the immune response, additional inflammatory signals delivered at the time of immunization have been shown to be key to shaping both the Fab and Fc-of the vaccine-induced immune response. Critically, the co-delivery of particular adjuvants, such as synthetic TLR ligands (e.g., TLR4 ligand&#8212;monophosphoryl lipid A (MPLA) and TLR7 ligand&#8212;Imiquimod) have been demonstrated to drive enhanced affinity maturation and epitope spreading in influenza vaccines in rhesus macaques (<xref rid="B137" ref-type="bibr">137</xref>). However, adjuvants have also been shown to drive distinct cytokine and chemokine expression profiles, shaping both T-helper quality and antibody subclass/isotype selection (<xref rid="F2" ref-type="fig">Fig. 2B and C</xref>). For example, the use of alum, the squalene-based oil-in-water emulsion MF59, and other adjuvants in mice drive enhanced functional IgG2a selection compared to standard largely IgG1 selection (<xref rid="B138" ref-type="bibr">138</xref>). Poly I:C elicits a highly balanced IgG1, IgG2b, and IgG2c response compared to alum or Addavax (<xref rid="B139" ref-type="bibr">139</xref>), pointing to the potential rational selection of adjuvants that give skewed or directed subclass selection in mice. Moreover, a study in non-human primates immunized with HIV envelope glycoprotein gp140 in different adjuvant formulations demonstrated adjuvant-induced differences in antibody glycan profiles, which further correlated with Fc-mediated effector functions (<xref rid="B29" ref-type="bibr">29</xref>). Specifically, formulation of the antigen with alum/TLR7 adjuvant resulted in the production of antibodies that strongly bound to the rhesus Fc&#947;Rs: Rh.Rc&#947;RIIa, Rh.Fc&#947;RIIb, and Rh.Fc&#947;RIIIa and exhibiting high ADCD and ADCP activity (<xref rid="B29" ref-type="bibr">29</xref>). Similarly, humans immunized with H5 Influenza HA adjuvanted with MF59 demonstrated higher levels of phagocytic-linked IgG1 and IgG3 <italic toggle="yes">via</italic> enhanced binding to Fc&#947;RIIa, but no enhancement in ADCC linked to poor Fc&#947;RIIIa binding (<xref rid="B140" ref-type="bibr">140</xref>). The increased IgG3 and phagocytic signal in the absence of ADCC were postulated to occur <italic toggle="yes">via</italic> altered Fc-glycosylation, pointing to skewed adjuvant B cell programming (<xref rid="B140" ref-type="bibr">140</xref>).</p><p>More recently, protein-based COVID-19 vaccines and boosters (prefusion spike) have been shown to elicit highly cross-reactive IgG when administered with the AS03 adjuvant (<xref rid="B141" ref-type="bibr">141</xref><xref rid="B142" ref-type="bibr">&#8211;</xref><xref rid="B143" ref-type="bibr">143</xref>). Moreover, the presence of AS03 in the immunization formulation was required for functional antibody responses. Notably, Fc&#947;R-binding antibodies were robustly induced when the prefusion spike was administered with AS03 compared to a formulation without AS03; in fact, a lower dose prefusion spike + AS03 elicited higher Fc&#947;R-binding than a higher dose prefusion spike without AS03 (1 &#181;g prefusion spike + AS03 vs 3 &#181;g prefusion spike &#8722;AS03). This was also true for non-neutralizing functions such as ADCD, ADCP, ADNP, and ADNKA where the lower dose vaccine with AS03 outperformed the higher dose vaccine without AS03. These non-human primates immunized with AS03 formulations showed strong protection against the SARS-CoV-2 challenge, and antibodies generated could be passively transferred and confer protection (<xref rid="B135" ref-type="bibr">135</xref>). While dissecting the protection afforded exclusively by Fc&#947;- and/or Fc&#945;-binding antibodies can be challenging in studies like these, it is clear that non-neutralizing antibodies whose functions are leveraged through their Fc domain play a substantial role in disease mitigation. The presence of adjuvants appears highly correlated with this.</p><p>Adjuvants appear to selectively skew antibody effector function both through selective isotype/subclass selection and altered Fc-glycosylation. Defining the overall impact of all clinically approved adjuvants may offer an opportunity to customize vaccine and adjuvant combinations based on the desired target immune profile. In addition, understanding what Fc-effector functions remain poorly programmable <italic toggle="yes">via</italic> the currently available adjuvants may point to novel opportunities for the design of novel classes of adjuvants that add value to vaccine development pipelines.</p></sec><sec id="s3-3"><title>Delivery systems</title><p>Finally, beyond the location of administration and adjuvant technologies, accumulating data suggest that the size, stoichiometry, shape, and arrangement of vaccine antigens can also shape the quality of the immune response (<xref rid="B144" ref-type="bibr">144</xref><xref rid="B145" ref-type="bibr">&#8211;</xref><xref rid="B147" ref-type="bibr">147</xref>). While single antigens can be less immunogenic than whole pathogens, diverse carrier particles including flexibly shaped and sized biodegradable nanoparticles [such as polylactic acid (PLA) or chitosan] (<xref rid="B148" ref-type="bibr">148</xref>, <xref rid="B149" ref-type="bibr">149</xref>), protein nanoparticles (<xref rid="B150" ref-type="bibr">150</xref>, <xref rid="B151" ref-type="bibr">151</xref>), inorganic nanocarriers (e.g., gold, carbon, and silica) (<xref rid="B152" ref-type="bibr">152</xref><xref rid="B153" ref-type="bibr">&#8211;</xref><xref rid="B155" ref-type="bibr">155</xref>) or liposomes (<xref rid="B156" ref-type="bibr">156</xref>), can mimic pathogens by triggering specific combinations of receptors, arming the immune system in a highly effective manner (<xref rid="F2" ref-type="fig">Fig. 2B</xref>). Moreover, it has been demonstrated that the controlled release of antigen from particles promotes affinity maturation through increased exposure and perpetual selection of B cells (<xref rid="B157" ref-type="bibr">157</xref>).</p><p>Distinct delivery systems have been linked with different Fc-mediated functions. Recent studies on COVID-19 vaccinations have given us previously unrealized details on this. For example, mRNA-based vaccines can elicit strong Fc&#947;R-binding antibody levels and non-neutralizing functions (<xref rid="B87" ref-type="bibr">87</xref>), which have been correlated with reduced disease severity (<xref rid="B91" ref-type="bibr">91</xref>). Importantly, while antigenic drift can decrease neutralizing antibody recognition (<xref rid="B158" ref-type="bibr">158</xref>, <xref rid="B159" ref-type="bibr">159</xref>), Fc&#947;R-binding antibodies and non-neutralizing functions can persist in mRNA-vaccinated individuals. Interestingly, NK-signaling antibodies generated by mRNA vaccines showed a stronger subdomain preference than an inactivated-vaccine-generated response (<xref rid="B130" ref-type="bibr">130</xref>, <xref rid="B133" ref-type="bibr">133</xref>). This could be due to how the antigen is presented, with mRNA-based COVID-19 vaccines encoding for a stabilized, prefusion spike, whereas an inactivated COVID-19 vaccine can contain spike in numerous conformations (<xref rid="B160" ref-type="bibr">160</xref><xref rid="B161" ref-type="bibr">&#8211;</xref><xref rid="B163" ref-type="bibr">163</xref>).</p><p>Adenovirus-based delivery systems have also demonstrated an ability to induce functional antibodies that were mostly ambivalent to genetic drift of the antigen, particularly in regards to complement deposition and NK-signaling (<xref rid="B164" ref-type="bibr">164</xref>). In addition, recombinant viral vectors can leverage viral carrier danger signals at the time of vaccination aimed at shaping the humoral immune responses. Viral vectors such as adenovirus-based platforms have been successfully employed for COVID-19 vaccines. However, population-based immunity toward the adenovirus vector itself needs to be taken into account when utilizing these platforms because neutralization/inactivation of the vector will decrease antigen production and processing. While emerging data clearly illustrate the highly distinct Fc-effector profiles leveraged by distinct viral vector strategies (<xref rid="B165" ref-type="bibr">165</xref>), the specific antibody profiles elicited by each vaccine vector remain incompletely understood. It is tempting to speculate that, like adjuvants, viral vectors could provide strategic information on how immunity is trained to most effectively drive a desired target immune profile.</p><p>Discreet mechanistic insight into how various delivery platforms/modalities shape Fc-effector function remains largely unexplored. While it is clear that platforms, adjuvants, and dose schedule impact how Fc functions are leveraged, future studies detailing how this process occurs are desperately needed, especially as the link between Fc functions and clinical outcomes becomes clearer.</p></sec></sec><sec sec-type="conclusions" id="s4"><title>CONCLUSION</title><p>While vaccines have revolutionized our ability to limit many previously highly lethal infectious diseases, as well as recently emerged pathogens, current vaccine design strategies and platforms can clearly be improved. This is of particular importance for pathogens with intrinsically high immune escape potential and those with multi-tissue life cycles. With our growing appreciation for the role of both the Fab and the Fc in mechanistic control against pathogens, next-generation vaccine strategies should leverage both ends of the antibody to provide a comprehensive protection strategy.</p><p>The COVID-19 pandemic presented itself at a critical moment in shifting this paradigm. The COVID-19 vaccines were developed, manufactured, and distributed within a stunning timeframe. As the pandemic progressed, genetic drift within the SARS-CoV-2 spike, particularly the receptor binding domain, allowed the virus to evade neutralizing antibodies (<xref rid="B158" ref-type="bibr">158</xref>, <xref rid="B159" ref-type="bibr">159</xref>, <xref rid="B166" ref-type="bibr">166</xref><xref rid="B167" ref-type="bibr">&#8211;</xref><xref rid="B173" ref-type="bibr">173</xref>). However, protection against disease did not see a corresponding drop, signifying that immune correlates of protection beyond neutralization existed. Fc-mediated functions of antibodies are key determinants of COVID-19 disease severity (<xref rid="B85" ref-type="bibr">85</xref>, <xref rid="B86" ref-type="bibr">86</xref>, <xref rid="B91" ref-type="bibr">91</xref>, <xref rid="B174" ref-type="bibr">174</xref><xref rid="B175" ref-type="bibr">&#8211;</xref><xref rid="B176" ref-type="bibr">176</xref>). Fully dissecting how various platforms, antigen designs, adjuvants, delivery modalities, and routes of administration affect these is critical. Therefore, to accomplish this goal, next-generation vaccine design will require a holistic understanding of the mechanisms of immune protection, taking into account all immune effector functions and the full potential of the humoral immune response. This will require a commitment to integrate and compare immune profiles across geographic, age, sex, gender, etc. demographics, and identifying signatures that predict outcomes. These commitments will not only help to reduce the disease burden of currently circulating pathogens but also allow for the rapid deployment of highly effective vaccines for emerging infectious diseases.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>We thank Galit Alter, Bruce Walker, Nancy Zimmerman, Mark and Lisa Schwartz, an anonymous donor, and Terry and Susan Ragon for their support. We acknowledge support from the SAMANA Kay MGH Research Scholar program, the Ragon Institute, and NIH. This work was funded by the NIH (1P01AI165072-01, 75N93019C00071, 75N93021C00029, and 5U19AI135995-05), the Bill and Melinda Gates Foundation (INV-031624), and the Massachusetts Consortium on Pathogen Readiness (MassCPR).</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>WHO</collab></person-group>. <year>2020</year>. <source>Immunization coverage</source>. <comment>Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://wwwwhoint/news-room/fact-sheets/detail/immunization-coverage" ext-link-type="uri">https://wwwwhoint/news-room/fact-sheets/detail/immunization-coverage</ext-link></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group>. <year>2009</year>. <source>State of the world&#8217;s vaccines and immunization</source>. <publisher-name>World Health Organization</publisher-name>.</mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>van Erp</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Luytjes</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Ferwerda</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>van Kasteren</surname><given-names>PB</given-names></string-name></person-group>. <year>2019</year>. <article-title>Fc-mediated antibody effector functions during respiratory syncytial virus infection and disease</article-title>. <source>Front Immunol</source><volume>10</volume>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2019.00548</pub-id><pub-id pub-id-type="pmcid">PMC6438959</pub-id><pub-id pub-id-type="pmid">30967872</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chen</surname><given-names>RT</given-names></string-name>, <string-name name-style="western"><surname>Markowitz</surname><given-names>LE</given-names></string-name>, <string-name name-style="western"><surname>Albrecht</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Stewart</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Mofenson</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Preblud</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Orenstein</surname><given-names>WA</given-names></string-name></person-group>. <year>1990</year>. <article-title>Measles antibody: reevaluation of protective titers</article-title>. <source>J Infect Dis</source><volume>162</volume>:<fpage>1036</fpage>&#8211;<lpage>1042</lpage>. doi:<pub-id pub-id-type="doi">10.1093/infdis/162.5.1036</pub-id><pub-id pub-id-type="pmid">2230231</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Haralambieva</surname><given-names>IH</given-names></string-name>, <string-name name-style="western"><surname>Kennedy</surname><given-names>RB</given-names></string-name>, <string-name name-style="western"><surname>Ovsyannikova</surname><given-names>IG</given-names></string-name>, <string-name name-style="western"><surname>Schaid</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Poland</surname><given-names>GA</given-names></string-name></person-group>. <year>2019</year>. <article-title>Current perspectives in assessing humoral immunity after measles vaccination</article-title>. <source>Expert Rev Vaccines</source><volume>18</volume>:<fpage>75</fpage>&#8211;<lpage>87</lpage>. doi:<pub-id pub-id-type="doi">10.1080/14760584.2019.1559063</pub-id><pub-id pub-id-type="pmid">30585753</pub-id><pub-id pub-id-type="pmcid">PMC6413513</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Schuerman</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Prymula</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Henckaerts</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Poolman</surname><given-names>J</given-names></string-name></person-group>. <year>2007</year>. <article-title>ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media</article-title>. <source>Vaccine</source><volume>25</volume>:<fpage>1962</fpage>&#8211;<lpage>1968</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2006.12.008</pub-id><pub-id pub-id-type="pmid">17258357</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Memoli</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Shaw</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Czajkowski</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Reed</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Athota</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Bristol</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Fargis</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Risos</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Powers</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Davey</surname><given-names>RT</given-names></string-name>, <string-name name-style="western"><surname>Taubenberger</surname><given-names>JK</given-names></string-name></person-group>. <year>2016</year>. <article-title>Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A/H1N1 virus healthy human challenge model</article-title>. <source>mBio</source><volume>7</volume>:<elocation-id>e00417-16</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/mBio.00417-16</pub-id><pub-id pub-id-type="pmid">27094330</pub-id><pub-id pub-id-type="pmcid">PMC4959521</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Boudreau</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2019</year>. <article-title>Extra-neutralizing FcR-mediated antibody functions for a universal influenza vaccine</article-title>. <source>Front Immunol</source><volume>10</volume>:<elocation-id>440</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2019.00440</pub-id><pub-id pub-id-type="pmid">30949165</pub-id><pub-id pub-id-type="pmcid">PMC6436086</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chiu</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Goulet</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Teplyakov</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gilliland</surname><given-names>GL</given-names></string-name></person-group>. <year>2019</year>. <article-title>Antibody structure and function: the basis for engineering therapeutics</article-title>. <source>Antibodies</source><volume>8</volume>:<fpage>55</fpage>. doi:<pub-id pub-id-type="doi">10.3390/antib8040055</pub-id><pub-id pub-id-type="pmid">31816964</pub-id><pub-id pub-id-type="pmcid">PMC6963682</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bournazos</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></string-name></person-group>. <year>2015</year>. <article-title>Fc&#947; receptor pathways during active and passive immunization</article-title>. <source>Immunol Rev</source><volume>268</volume>:<fpage>88</fpage>&#8211;<lpage>103</lpage>. doi:<pub-id pub-id-type="doi">10.1111/imr.12343</pub-id><pub-id pub-id-type="pmid">26497515</pub-id><pub-id pub-id-type="pmcid">PMC7556827</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ben Mkaddem</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Benhamou</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Monteiro</surname><given-names>RC</given-names></string-name></person-group>. <year>2019</year>. <article-title>Understanding Fc receptor involvement in inflammatory diseases: from mechanisms to new therapeutic tools</article-title>. <source>Front Immunol</source><volume>10</volume>:<elocation-id>811</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2019.00811</pub-id><pub-id pub-id-type="pmid">31057544</pub-id><pub-id pub-id-type="pmcid">PMC6481281</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bai</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Ye</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Tesar</surname><given-names>DB</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Bj&#246;rkman</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Roopenian</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>X</given-names></string-name></person-group>. <year>2011</year>. <article-title>Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>108</volume>:<fpage>18406</fpage>&#8211;<lpage>18411</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1115348108</pub-id><pub-id pub-id-type="pmid">22042859</pub-id><pub-id pub-id-type="pmcid">PMC3215070</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Oliveira</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Kretzschmar</surname><given-names>GC</given-names></string-name>, <string-name name-style="western"><surname>Dos Santos</surname><given-names>ACM</given-names></string-name>, <string-name name-style="western"><surname>Camargo</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Nisihara</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Farias</surname><given-names>TDJ</given-names></string-name>, <string-name name-style="western"><surname>Franke</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Wittig</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Schmidt</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Busch</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Petzl-Erler</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Boldt</surname><given-names>ABW</given-names></string-name></person-group>. <year>2019</year>. <article-title>Complement receptor 1 (CR1, CD35) polymorphisms and soluble CR1: a proposed anti-inflammatory role to quench the fire of "fogo selvagem" pemphigus foliaceus</article-title>. <source>Front Immunol</source><volume>10</volume>:<fpage>2585</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2019.02585</pub-id><pub-id pub-id-type="pmid">31824479</pub-id><pub-id pub-id-type="pmcid">PMC6883348</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gadjeva</surname><given-names>M</given-names></string-name></person-group>. <year>2014</year>. <article-title>The complement system. Overview</article-title>. <source>Methods Mol Biol</source><volume>1100</volume>:<fpage>1</fpage>&#8211;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-1-62703-724-2_1</pub-id><pub-id pub-id-type="pmid">24218246</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rossbacher</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Shlomchik</surname><given-names>MJ</given-names></string-name></person-group>. <year>2003</year>. <article-title>The B cell receptor itself can activate complement to provide the complement receptor 1/2 ligand required to enhance B cell immune responses in vivo</article-title>. <source>J Exp Med</source><volume>198</volume>:<fpage>591</fpage>&#8211;<lpage>602</lpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.20022042</pub-id><pub-id pub-id-type="pmid">12925675</pub-id><pub-id pub-id-type="pmcid">PMC2194168</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nimmerjahn</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></string-name></person-group>. <year>2008</year>. <article-title>Fcgamma receptors as regulators of immune responses</article-title>. <source>Nat Rev Immunol</source><volume>8</volume>:<fpage>34</fpage>&#8211;<lpage>47</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nri2206</pub-id><pub-id pub-id-type="pmid">18064051</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kang</surname><given-names>TH</given-names></string-name>, <string-name name-style="western"><surname>Jung</surname><given-names>ST</given-names></string-name></person-group>. <year>2019</year>. <article-title>Boosting therapeutic potency of antibodies by taming Fc domain functions</article-title>. <source>Exp Mol Med</source><volume>51</volume>:<fpage>1</fpage>&#8211;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s12276-019-0345-9</pub-id><pub-id pub-id-type="pmcid">PMC6859160</pub-id><pub-id pub-id-type="pmid">31735912</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>de Taeye</surname><given-names>SW</given-names></string-name>, <string-name name-style="western"><surname>Rispens</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Vidarsson</surname><given-names>G</given-names></string-name></person-group>. <year>2019</year>. <article-title>The ligands for human IgG and their effector functions</article-title>. <source>Antibodies (Basel)</source><volume>8</volume>:<elocation-id>30</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/antib8020030</pub-id><pub-id pub-id-type="pmid">31544836</pub-id><pub-id pub-id-type="pmcid">PMC6640714</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Stavnezer</surname><given-names>Janet</given-names></string-name>, <string-name name-style="western"><surname>Guikema</surname><given-names>JEJ</given-names></string-name>, <string-name name-style="western"><surname>Schrader</surname><given-names>CE</given-names></string-name></person-group>. <year>2008</year>. <article-title>Mechanism and regulation of class switch recombination</article-title>. <source>Annu Rev Immunol</source><volume>26</volume>:<fpage>261</fpage>&#8211;<lpage>292</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.immunol.26.021607.090248</pub-id><pub-id pub-id-type="pmid">18370922</pub-id><pub-id pub-id-type="pmcid">PMC2707252</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Stavnezer</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Schrader</surname><given-names>CE</given-names></string-name></person-group>. <year>2014</year>. <article-title>IgH chain class switch recombination: mechanism and regulation</article-title>. <source>J Immunol</source><volume>193</volume>:<fpage>5370</fpage>&#8211;<lpage>5378</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.1401849</pub-id><pub-id pub-id-type="pmid">25411432</pub-id><pub-id pub-id-type="pmcid">PMC4447316</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Irani</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Guy</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Andrew</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Beeson</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Ramsland</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Richards</surname><given-names>JS</given-names></string-name></person-group>. <year>2015</year>. <article-title>Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases</article-title>. <source>Mol Immunol</source><volume>67</volume>:<fpage>171</fpage>&#8211;<lpage>182</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molimm.2015.03.255</pub-id><pub-id pub-id-type="pmid">25900877</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bruhns</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Iannascoli</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>England</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Mancardi</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Fernandez</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Jorieux</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Da&#235;ron</surname><given-names>M</given-names></string-name></person-group>. <year>2009</year>. <article-title>Specificity and affinity of human Fc&#947; receptors and their polymorphic variants for human IgG subclasses</article-title>. <source>Blood</source><volume>113</volume>:<fpage>3716</fpage>&#8211;<lpage>3725</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2008-09-179754</pub-id><pub-id pub-id-type="pmid">19018092</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Anthony</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Nimmerjahn</surname><given-names>F</given-names></string-name></person-group>. <year>2011</year>. <article-title>The role of differential IgG glycosylation in the interaction of antibodies with Fc&#947;rs in vivo</article-title>. <source>Curr Opin Organ Transplant</source><volume>16</volume>:<fpage>7</fpage>&#8211;<lpage>14</lpage>. doi:<pub-id pub-id-type="doi">10.1097/MOT.0b013e328342538f</pub-id><pub-id pub-id-type="pmid">21150612</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Falconer</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Subedi</surname><given-names>GP</given-names></string-name>, <string-name name-style="western"><surname>Marcella</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Barb</surname><given-names>AW</given-names></string-name></person-group>. <year>2018</year>. <article-title>Antibody fucosylation lowers the FcgammaRIIIa/CD16a affinity by limiting the conformations sampled by the N162-glycan</article-title>. <source>ACS Chem Biol</source><volume>13</volume>:<fpage>2179</fpage>&#8211;<lpage>2189</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acschembio.8b00342</pub-id><pub-id pub-id-type="pmid">30016589</pub-id><pub-id pub-id-type="pmcid">PMC6415948</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kaneko</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Nimmerjahn</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></string-name></person-group>. <year>2006</year>. <article-title>Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation</article-title>. <source>Science</source><volume>313</volume>:<fpage>670</fpage>&#8211;<lpage>673</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1129594</pub-id><pub-id pub-id-type="pmid">16888140</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dekkers</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Rispens</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Vidarsson</surname><given-names>G</given-names></string-name></person-group>. <year>2018</year>. <article-title>Novel concepts of altered immunoglobulin G galactosylation in autoimmune diseases</article-title>. <source>Front Immunol</source><volume>9</volume>:<fpage>553</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2018.00553</pub-id><pub-id pub-id-type="pmid">29616041</pub-id><pub-id pub-id-type="pmcid">PMC5867308</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Selman</surname><given-names>MHJ</given-names></string-name>, <string-name name-style="western"><surname>de Jong</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Soonawala</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Kroon</surname><given-names>FP</given-names></string-name>, <string-name name-style="western"><surname>Adegnika</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Deelder</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Hokke</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Yazdanbakhsh</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wuhrer</surname><given-names>M</given-names></string-name></person-group>. <year>2012</year>. <article-title>Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination</article-title>. <source>Mol Cell Proteomics</source><volume>11</volume>:<elocation-id>M111</elocation-id>. doi:<pub-id pub-id-type="doi">10.1074/mcp.M111.014563</pub-id><pub-id pub-id-type="pmcid">PMC3322571</pub-id><pub-id pub-id-type="pmid">22184099</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lofano</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Gorman</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Yousif</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>W-H</given-names></string-name>, <string-name name-style="western"><surname>Fox</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Dugast</surname><given-names>A-S</given-names></string-name>, <string-name name-style="western"><surname>Ackerman</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Suscovich</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Weiner</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Barouch</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Streeck</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Little</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Richman</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Lauffenburger</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Walker</surname><given-names>BD</given-names></string-name>, <string-name name-style="western"><surname>Diamond</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2018</year>. <article-title>Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement</article-title>. <source>Sci Immunol</source><volume>3</volume>:<elocation-id>eaat7796</elocation-id>. doi:<pub-id pub-id-type="doi">10.1126/sciimmunol.aat7796</pub-id><pub-id pub-id-type="pmid">30120121</pub-id><pub-id pub-id-type="pmcid">PMC6298214</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Francica</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Zak</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Linde</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Siena</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Juraska</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yates</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Gunn</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>De Gregorio</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Flynn</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Valiante</surname><given-names>NM</given-names></string-name>, <string-name name-style="western"><surname>Malyala</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Barnett</surname><given-names>SW</given-names></string-name>, <string-name name-style="western"><surname>Sarkar</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Jain</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ackerman</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Alam</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ferrari</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Salazar</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Tomaras</surname><given-names>GD</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Hagan</surname><given-names>DT</given-names></string-name>, <string-name name-style="western"><surname>Aderem</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Seder</surname><given-names>RA</given-names></string-name></person-group>. <year>2017</year>. <article-title>Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs</article-title>. <source>Blood Adv</source><volume>1</volume>:<fpage>2329</fpage>&#8211;<lpage>2342</lpage>. doi:<pub-id pub-id-type="doi">10.1182/bloodadvances.2017011411</pub-id><pub-id pub-id-type="pmid">29296883</pub-id><pub-id pub-id-type="pmcid">PMC5729628</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wang</surname><given-names>TT</given-names></string-name>, <string-name name-style="western"><surname>Maamary</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>GS</given-names></string-name>, <string-name name-style="western"><surname>Bournazos</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Krammer</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Schlesinger</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Palese</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ahmed</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></string-name></person-group>. <year>2015</year>. <article-title>Anti-HA glycoforms drive B cell affinity selection and determine influenza vaccine efficacy</article-title>. <source>Cell</source><volume>162</volume>:<fpage>160</fpage>&#8211;<lpage>169</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2015.06.026</pub-id><pub-id pub-id-type="pmid">26140596</pub-id><pub-id pub-id-type="pmcid">PMC4594835</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mahan</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Jennewein</surname><given-names>MF</given-names></string-name>, <string-name name-style="western"><surname>Suscovich</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Dionne</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Tedesco</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Streeck</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Pau</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Schuitemaker</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Francis</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Fast</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Laufer</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Walker</surname><given-names>BD</given-names></string-name>, <string-name name-style="western"><surname>Baden</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Barouch</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Trkola</surname><given-names>A</given-names></string-name></person-group>. <year>2016</year>. <article-title>Antigen-specific antibody glycosylation is regulated via vaccination</article-title>. <source>PLoS Pathog</source><volume>12</volume>:<elocation-id>e1005456</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1005456</pub-id><pub-id pub-id-type="pmid">26982805</pub-id><pub-id pub-id-type="pmcid">PMC4794126</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Maul</surname><given-names>RW</given-names></string-name>, <string-name name-style="western"><surname>Gearhart</surname><given-names>PJ</given-names></string-name></person-group>. <year>2010</year>. <article-title>AID and somatic hypermutation</article-title>. <source>Adv Immunol</source><volume>105</volume>:<fpage>159</fpage>&#8211;<lpage>191</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0065-2776(10)05006-6</pub-id><pub-id pub-id-type="pmid">20510733</pub-id><pub-id pub-id-type="pmcid">PMC2954419</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Prakash</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>RE</given-names></string-name>, <string-name name-style="western"><surname>Prakash</surname><given-names>L</given-names></string-name></person-group>. <year>2005</year>. <article-title>Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function</article-title>. <source>Annu Rev Biochem</source><volume>74</volume>:<fpage>317</fpage>&#8211;<lpage>353</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.biochem.74.082803.133250</pub-id><pub-id pub-id-type="pmid">15952890</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Matsuda</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Bebenek</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Masutani</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Rogozin</surname><given-names>IB</given-names></string-name>, <string-name name-style="western"><surname>Hanaoka</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Kunkel</surname><given-names>TA</given-names></string-name></person-group>. <year>2001</year>. <article-title>Error rate and specificity of human and murine DNA polymerase eta</article-title>. <source>J Mol Biol</source><volume>312</volume>:<fpage>335</fpage>&#8211;<lpage>346</lpage>. doi:<pub-id pub-id-type="doi">10.1006/jmbi.2001.4937</pub-id><pub-id pub-id-type="pmid">11554790</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pavlov</surname><given-names>YI</given-names></string-name>, <string-name name-style="western"><surname>Rogozin</surname><given-names>IB</given-names></string-name>, <string-name name-style="western"><surname>Galkin</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Aksenova</surname><given-names>AY</given-names></string-name>, <string-name name-style="western"><surname>Hanaoka</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Rada</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Kunkel</surname><given-names>TA</given-names></string-name></person-group>. <year>2002</year>. <article-title>Correlation of somatic hypermutation specificity and A-T base pair substitution errors by DNA polymerase eta during copying of a mouse immunoglobulin kappa light chain transgene</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>99</volume>:<fpage>9954</fpage>&#8211;<lpage>9959</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.152126799</pub-id><pub-id pub-id-type="pmid">12119399</pub-id><pub-id pub-id-type="pmcid">PMC126606</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Di Noia</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Neuberger</surname><given-names>MS</given-names></string-name></person-group>. <year>2007</year>. <article-title>Molecular mechanisms of antibody somatic hypermutation</article-title>. <source>Annu Rev Biochem</source><volume>76</volume>:<fpage>1</fpage>&#8211;<lpage>22</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.biochem.76.061705.090740</pub-id><pub-id pub-id-type="pmid">17328676</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lieber</surname><given-names>MR</given-names></string-name></person-group>. <year>2010</year>. <article-title>The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway</article-title>. <source>Annu Rev Biochem</source><volume>79</volume>:<fpage>181</fpage>&#8211;<lpage>211</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.biochem.052308.093131</pub-id><pub-id pub-id-type="pmid">20192759</pub-id><pub-id pub-id-type="pmcid">PMC3079308</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Dai</surname><given-names>HQ</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Alt</surname><given-names>FW</given-names></string-name></person-group>. <year>2022</year>. <article-title>The role of chromatin loop extrusion in antibody diversification</article-title>. <source>Nat Rev Immunol</source><volume>22</volume>:<fpage>550</fpage>&#8211;<lpage>566</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41577-022-00679-3</pub-id><pub-id pub-id-type="pmid">35169260</pub-id><pub-id pub-id-type="pmcid">PMC9376198</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sela-Culang</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Kunik</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Ofran</surname><given-names>Y</given-names></string-name></person-group>. <year>2013</year>. <article-title>The structural basis of antibody-antigen recognition</article-title>. <source>Front Immunol</source><volume>4</volume>:<elocation-id>302</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2013.00302</pub-id><pub-id pub-id-type="pmid">24115948</pub-id><pub-id pub-id-type="pmcid">PMC3792396</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chothia</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Lesk</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Tramontano</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Levitt</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Smith-Gill</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Air</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Sheriff</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Padlan</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Davies</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Tulip</surname><given-names>WR</given-names></string-name>, <string-name name-style="western"><surname>Colman</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Spinelli</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Alzari</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Poljak</surname><given-names>RJ</given-names></string-name></person-group>. <year>1989</year>. <article-title>Conformations of immunoglobulin hypervariable regions</article-title>. <source>Nature</source><volume>342</volume>:<fpage>877</fpage>&#8211;<lpage>883</lpage>. doi:<pub-id pub-id-type="doi">10.1038/342877a0</pub-id><pub-id pub-id-type="pmid">2687698</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Collis</surname><given-names>AVJ</given-names></string-name>, <string-name name-style="western"><surname>Brouwer</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Martin</surname><given-names>ACR</given-names></string-name></person-group>. <year>2003</year>. <article-title>Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen</article-title>. <source>J Mol Biol</source><volume>325</volume>:<fpage>337</fpage>&#8211;<lpage>354</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0022-2836(02)01222-6</pub-id><pub-id pub-id-type="pmid">12488099</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Feng</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Seija</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Di Noia</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Martin</surname><given-names>A</given-names></string-name></person-group>. <year>2020</year>. <article-title>AID in antibody diversification: there and back again</article-title>. <source>Trends Immunol</source><volume>41</volume>:<fpage>586</fpage>&#8211;<lpage>600</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.it.2020.04.009</pub-id><pub-id pub-id-type="pmid">32434680</pub-id><pub-id pub-id-type="pmcid">PMC7183997</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wibmer</surname><given-names>CK</given-names></string-name>, <string-name name-style="western"><surname>Moore</surname><given-names>PL</given-names></string-name>, <string-name name-style="western"><surname>Morris</surname><given-names>L</given-names></string-name></person-group>. <year>2015</year>. <article-title>HIV broadly neutralizing antibody targets</article-title>. <source>Curr Opin HIV AIDS</source><volume>10</volume>:<fpage>135</fpage>&#8211;<lpage>143</lpage>. doi:<pub-id pub-id-type="doi">10.1097/COH.0000000000000153</pub-id><pub-id pub-id-type="pmid">25760932</pub-id><pub-id pub-id-type="pmcid">PMC4437463</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Andrade</surname><given-names>DV</given-names></string-name>, <string-name name-style="western"><surname>Warnes</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Young</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Katzelnick</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Balmaseda</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>de Silva</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Baric</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Harris</surname><given-names>E</given-names></string-name></person-group>. <year>2019</year>. <article-title>Tracking the polyclonal neutralizing antibody response to a dengue virus serotype 1 type-specific epitope across two populations in Asia and the Americas</article-title>. <source>Sci Rep</source><volume>9</volume>:<fpage>16258</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-019-52511-z</pub-id><pub-id pub-id-type="pmid">31700029</pub-id><pub-id pub-id-type="pmcid">PMC6838341</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bournazos</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Chow</surname><given-names>S-K</given-names></string-name>, <string-name name-style="western"><surname>Abboud</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></string-name></person-group>. <year>2014</year>. <article-title>Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity</article-title>. <source>J Clin Invest</source><volume>124</volume>:<fpage>725</fpage>&#8211;<lpage>729</lpage>. doi:<pub-id pub-id-type="doi">10.1172/JCI72676</pub-id><pub-id pub-id-type="pmid">24401277</pub-id><pub-id pub-id-type="pmcid">PMC3904629</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wenzel</surname><given-names>EV</given-names></string-name>, <string-name name-style="western"><surname>Bosnak</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Tierney</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Schubert</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>D&#252;bel</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Efstratiou</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sesardic</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Stickings</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Hust</surname><given-names>M</given-names></string-name></person-group>. <year>2020</year>. <article-title>Human antibodies neutralizing diphtheria toxin in vitro and in vivo</article-title>. <source>Sci Rep</source><volume>10</volume>:<fpage>571</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-019-57103-5</pub-id><pub-id pub-id-type="pmid">31953428</pub-id><pub-id pub-id-type="pmcid">PMC6969050</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bournazos</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Klein</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Pietzsch</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Seaman</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Nussenzweig</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></string-name></person-group>. <year>2014</year>. <article-title>Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity</article-title>. <source>Cell</source><volume>158</volume>:<fpage>1243</fpage>&#8211;<lpage>1253</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2014.08.023</pub-id><pub-id pub-id-type="pmid">25215485</pub-id><pub-id pub-id-type="pmcid">PMC4167398</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fox</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mai</surname><given-names>LQ</given-names></string-name>, <string-name name-style="western"><surname>Thanh</surname><given-names>LT</given-names></string-name>, <string-name name-style="western"><surname>Wolbers</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Le Khanh Hang</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Thai</surname><given-names>PQ</given-names></string-name>, <string-name name-style="western"><surname>Thi Thu Yen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Minh Hoa</surname><given-names>LN</given-names></string-name>, <string-name name-style="western"><surname>Bryant</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Duong</surname><given-names>TN</given-names></string-name>, <string-name name-style="western"><surname>Thoang</surname><given-names>DD</given-names></string-name>, <string-name name-style="western"><surname>Barr</surname><given-names>IG</given-names></string-name>, <string-name name-style="western"><surname>Wertheim</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Farrar</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hien</surname><given-names>NT</given-names></string-name>, <string-name name-style="western"><surname>Horby</surname><given-names>P</given-names></string-name></person-group>. <year>2015</year>. <article-title>Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection</article-title>. <source>J Infect</source><volume>70</volume>:<fpage>187</fpage>&#8211;<lpage>196</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jinf.2014.09.003</pub-id><pub-id pub-id-type="pmid">25224643</pub-id><pub-id pub-id-type="pmcid">PMC4309889</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tumpey</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Garc&#237;a-Sastre</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Taubenberger</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Palese</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Swayne</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Pantin-Jackwood</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Schultz-Cherry</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sol&#243;rzano</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Van Rooijen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Katz</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Basler</surname><given-names>CF</given-names></string-name></person-group>. <year>2005</year>. <article-title>Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice</article-title>. <source>J Virol</source><volume>79</volume>:<fpage>14933</fpage>&#8211;<lpage>14944</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JVI.79.23.14933-14944.2005</pub-id><pub-id pub-id-type="pmid">16282492</pub-id><pub-id pub-id-type="pmcid">PMC1287592</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Brandenburg</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Koudstaal</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Goudsmit</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Klaren</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Bujny</surname><given-names>MV</given-names></string-name>, <string-name name-style="western"><surname>Korse</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kwaks</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Otterstrom</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Juraszek</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>van Oijen</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Vogels</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Friesen</surname><given-names>RHE</given-names></string-name></person-group>. <year>2013</year>. <article-title>Mechanisms of hemagglutinin targeted influenza virus neutralization</article-title>. <source>PLoS One</source><volume>8</volume>:<elocation-id>e80034</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0080034</pub-id><pub-id pub-id-type="pmid">24348996</pub-id><pub-id pub-id-type="pmcid">PMC3862845</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ekiert</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Friesen</surname><given-names>RHE</given-names></string-name>, <string-name name-style="western"><surname>Bhabha</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Kwaks</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Jongeneelen</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Ophorst</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Cox</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Korse</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Brandenburg</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Vogels</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Brakenhoff</surname><given-names>JPJ</given-names></string-name>, <string-name name-style="western"><surname>Kompier</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Koldijk</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Cornelissen</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Poon</surname><given-names>LLM</given-names></string-name>, <string-name name-style="western"><surname>Peiris</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Koudstaal</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Wilson</surname><given-names>IA</given-names></string-name>, <string-name name-style="western"><surname>Goudsmit</surname><given-names>J</given-names></string-name></person-group>. <year>2011</year>. <article-title>A highly conserved neutralizing epitope on group 2 influenza A viruses</article-title>. <source>Science</source><volume>333</volume>:<fpage>843</fpage>&#8211;<lpage>850</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1204839</pub-id><pub-id pub-id-type="pmid">21737702</pub-id><pub-id pub-id-type="pmcid">PMC3210727</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>He</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>GS</given-names></string-name>, <string-name name-style="western"><surname>Mullarkey</surname><given-names>CE</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Lam</surname><given-names>MMW</given-names></string-name>, <string-name name-style="western"><surname>Krammer</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Henry</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Wilson</surname><given-names>PC</given-names></string-name>, <string-name name-style="western"><surname>Ashkar</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Palese</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>MS</given-names></string-name></person-group>. <year>2016</year>. <article-title>Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>113</volume>:<fpage>11931</fpage>&#8211;<lpage>11936</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1609316113</pub-id><pub-id pub-id-type="pmid">27698132</pub-id><pub-id pub-id-type="pmcid">PMC5081650</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rattan</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Pawar</surname><given-names>SD</given-names></string-name>, <string-name name-style="western"><surname>Nawadkar</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Kulkarni</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Lal</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Mullick</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sahu</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Thomas</surname><given-names>PG</given-names></string-name></person-group>. <year>2017</year>. <article-title>Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection</article-title>. <source>PLoS Pathog</source><volume>13</volume>:<elocation-id>e1006248</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1006248</pub-id><pub-id pub-id-type="pmid">28301559</pub-id><pub-id pub-id-type="pmcid">PMC5354441</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Getahun</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Cambier</surname><given-names>JC</given-names></string-name></person-group>. <year>2015</year>. <article-title>Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling</article-title>. <source>Immunol Rev</source><volume>268</volume>:<fpage>66</fpage>&#8211;<lpage>73</lpage>. doi:<pub-id pub-id-type="doi">10.1111/imr.12336</pub-id><pub-id pub-id-type="pmid">26497513</pub-id><pub-id pub-id-type="pmcid">PMC4621791</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mayadas</surname><given-names>TN</given-names></string-name>, <string-name name-style="western"><surname>Cullere</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Lowell</surname><given-names>CA</given-names></string-name></person-group>. <year>2014</year>. <article-title>The multifaceted functions of neutrophils</article-title>. <source>Annu Rev Pathol</source><volume>9</volume>:<fpage>181</fpage>&#8211;<lpage>218</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev-pathol-020712-164023</pub-id><pub-id pub-id-type="pmid">24050624</pub-id><pub-id pub-id-type="pmcid">PMC4277181</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Aleyd</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>van Hout</surname><given-names>MWM</given-names></string-name>, <string-name name-style="western"><surname>Ganzevles</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Hoeben</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Everts</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Bakema</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>van Egmond</surname><given-names>M</given-names></string-name></person-group>. <year>2014</year>. <article-title>IgA enhances NETosis and release of neutrophil extracellular traps by polymorphonuclear cells via Fc&#945; receptor I</article-title>. <source>J Immunol</source><volume>192</volume>:<fpage>2374</fpage>&#8211;<lpage>2383</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.1300261</pub-id><pub-id pub-id-type="pmid">24493821</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Savina</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Amigorena</surname><given-names>S</given-names></string-name></person-group>. <year>2007</year>. <article-title>Phagocytosis and antigen presentation in dendritic cells</article-title>. <source>Immunol Rev</source><volume>219</volume>:<fpage>143</fpage>&#8211;<lpage>156</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1600-065X.2007.00552.x</pub-id><pub-id pub-id-type="pmid">17850487</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nepomuceno</surname><given-names>RR</given-names></string-name>, <string-name name-style="western"><surname>Tenner</surname><given-names>AJ</given-names></string-name></person-group>. <year>1998</year>. <article-title>C1qR<sub>p</sub>, the C1q receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage, endothelial cells, and platelets</article-title>. <source>J Immunol</source><volume>160</volume>:<fpage>1929</fpage>&#8211;<lpage>1935</lpage>.<pub-id pub-id-type="pmid">9469455</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ross</surname><given-names>GD</given-names></string-name>, <string-name name-style="western"><surname>Newman</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Lambris</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Devery-Pocius</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Cain</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Lachmann</surname><given-names>PJ</given-names></string-name></person-group>. <year>1983</year>. <article-title>Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin</article-title>. <source>J Exp Med</source><volume>158</volume>:<fpage>334</fpage>&#8211;<lpage>352</lpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.158.2.334</pub-id><pub-id pub-id-type="pmid">6224880</pub-id><pub-id pub-id-type="pmcid">PMC2187331</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jennewein</surname><given-names>MF</given-names></string-name>, <string-name name-style="western"><surname>Kosikova</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Noelette</surname><given-names>FJ</given-names></string-name>, <string-name name-style="western"><surname>Radvak</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Boudreau</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Campbell</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>WH</given-names></string-name>, <string-name name-style="western"><surname>Xie</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Pasetti</surname><given-names>MF</given-names></string-name></person-group>. <year>2022</year>. <article-title>Functional and structural modifications of influenza antibodies during pregnancy</article-title>. <source>iScience</source><volume>25</volume>:<fpage>104088</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.isci.2022.104088</pub-id><pub-id pub-id-type="pmid">35402869</pub-id><pub-id pub-id-type="pmcid">PMC8991102</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Leitner</surname><given-names>WW</given-names></string-name>, <string-name name-style="western"><surname>Haraway</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Pierson</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Bergmann-Leitner</surname><given-names>ES</given-names></string-name></person-group>. <year>2020</year>. <article-title>Role of opsonophagocytosis in immune protection against malaria</article-title>. <source>Vaccines (Basel)</source><volume>8</volume>:<elocation-id>264</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/vaccines8020264</pub-id><pub-id pub-id-type="pmid">32486320</pub-id><pub-id pub-id-type="pmcid">PMC7350021</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kwon</surname><given-names>Y-C</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Meyer</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Di Bisceglie</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Ray</surname><given-names>R</given-names></string-name></person-group>. <year>2016</year>. <article-title>Distinct CD55 isoform synthesis and inhibition of complement-dependent cytolysis by hepatitis C virus</article-title>. <source>J Immunol</source><volume>197</volume>:<fpage>1127</fpage>&#8211;<lpage>1136</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.1600631</pub-id><pub-id pub-id-type="pmid">27357152</pub-id><pub-id pub-id-type="pmcid">PMC4976035</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wang</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>de Jong</surname><given-names>RN</given-names></string-name>, <string-name name-style="western"><surname>van den Bremer</surname><given-names>ETJ</given-names></string-name>, <string-name name-style="western"><surname>Beurskens</surname><given-names>FJ</given-names></string-name>, <string-name name-style="western"><surname>Labrijn</surname><given-names>AF</given-names></string-name>, <string-name name-style="western"><surname>Ugurlar</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Gros</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Schuurman</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Parren</surname><given-names>PWHI</given-names></string-name>, <string-name name-style="western"><surname>Heck</surname><given-names>AJR</given-names></string-name></person-group>. <year>2016</year>. <article-title>Molecular basis of assembly and activation of complement component C1 in complex with immunoglobulin G1 and antigen</article-title>. <source>Mol Cell</source><volume>63</volume>:<fpage>135</fpage>&#8211;<lpage>145</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2016.05.016</pub-id><pub-id pub-id-type="pmid">27320199</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Huber</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>B&#225;nki</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Lengauer</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Stoiber</surname><given-names>H</given-names></string-name></person-group>. <year>2011</year>. <article-title>Emerging role for complement in HIV infection</article-title>. <source>Curr Opin HIV AIDS</source><volume>6</volume>:<fpage>419</fpage>&#8211;<lpage>426</lpage>. doi:<pub-id pub-id-type="doi">10.1097/COH.0b013e3283495a26</pub-id><pub-id pub-id-type="pmid">21825871</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dunkelberger</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>W-C</given-names></string-name></person-group>. <year>2010</year>. <article-title>Complement and its role in innate and adaptive immune responses</article-title>. <source>Cell Res</source><volume>20</volume>:<fpage>34</fpage>&#8211;<lpage>50</lpage>. doi:<pub-id pub-id-type="doi">10.1038/cr.2009.139</pub-id><pub-id pub-id-type="pmid">20010915</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fern&#225;ndez</surname><given-names>FJ</given-names></string-name>, <string-name name-style="western"><surname>Santos-L&#243;pez</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mart&#237;nez-Barricarte</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Querol-Garc&#237;a</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mart&#237;n-Merinero</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Navas-Yuste</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Savko</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Shepard</surname><given-names>WE</given-names></string-name>, <string-name name-style="western"><surname>Rodr&#237;guez de C&#243;rdoba</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Vega</surname><given-names>MC</given-names></string-name></person-group>. <year>2022</year>. <article-title>The crystal structure of iC3b-CR3 &#945;I reveals a modular recognition of the main opsonin iC3b by the CR3 integrin receptor</article-title>. <source>Nat Commun</source><volume>13</volume>:<fpage>1955</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-022-29580-2</pub-id><pub-id pub-id-type="pmid">35413960</pub-id><pub-id pub-id-type="pmcid">PMC9005620</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>van Lookeren Campagne</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wiesmann</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>EJ</given-names></string-name></person-group>. <year>2007</year>. <article-title>Macrophage complement receptors and pathogen clearance</article-title>. <source>Cell Microbiol</source><volume>9</volume>:<fpage>2095</fpage>&#8211;<lpage>2102</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1462-5822.2007.00981.x</pub-id><pub-id pub-id-type="pmid">17590164</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>van Lookeren Campagne</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Verschoor</surname><given-names>A</given-names></string-name></person-group>. <year>2018</year>. <article-title>Pathogen clearance and immune adherence "revisited": immuno-regulatory roles for CRIg</article-title>. <source>Semin Immunol</source><volume>37</volume>:<fpage>4</fpage>&#8211;<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smim.2018.02.007</pub-id><pub-id pub-id-type="pmid">29573978</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>YW</given-names></string-name></person-group>. <year>2019</year>. <article-title>The complement receptors C3aR and C5aR are a new class of immune checkpoint receptor in cancer immunotherapy</article-title>. <source>Front Immunol</source><volume>10</volume>:<elocation-id>1574</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2019.01574</pub-id><pub-id pub-id-type="pmid">31379815</pub-id><pub-id pub-id-type="pmcid">PMC6658873</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Feng</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Deng</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Tian</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Bin</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Fu</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Shao</surname><given-names>Z</given-names></string-name></person-group>. <year>2023</year>. <article-title>Mechanism of activation and biased signaling in complement receptor C5aR1</article-title>. <source>Cell Res</source><volume>33</volume>:<fpage>312</fpage>&#8211;<lpage>324</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41422-023-00779-2</pub-id><pub-id pub-id-type="pmid">36806352</pub-id><pub-id pub-id-type="pmcid">PMC9937529</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Skokowa</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ali</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Felda</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Kumar</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Konrad</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Shushakova</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Schmidt</surname><given-names>RE</given-names></string-name>, <string-name name-style="western"><surname>Piekorz</surname><given-names>RP</given-names></string-name>, <string-name name-style="western"><surname>N&#252;rnberg</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Spicher</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Birnbaumer</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zwirner</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Claassens</surname><given-names>JWC</given-names></string-name>, <string-name name-style="western"><surname>Verbeek</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>van Rooijen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>K&#246;hl</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Gessner</surname><given-names>JE</given-names></string-name></person-group>. <year>2005</year>. <article-title>Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation</article-title>. <source>J Immunol</source><volume>174</volume>:<fpage>3041</fpage>&#8211;<lpage>3050</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.174.5.3041</pub-id><pub-id pub-id-type="pmid">15728518</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Li</surname><given-names>XX</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Kemper</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Woodruff</surname><given-names>TM</given-names></string-name></person-group>. <year>2019</year>. <article-title>The complement receptor C5aR2: a powerful modulator of innate and adaptive immunity</article-title>. <source>J Immunol</source><volume>202</volume>:<fpage>3339</fpage>&#8211;<lpage>3348</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.1900371</pub-id><pub-id pub-id-type="pmid">31160390</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Platonov</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Vershinina</surname><given-names>IV</given-names></string-name>, <string-name name-style="western"><surname>K&#228;yhty</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Fijen</surname><given-names>CAP</given-names></string-name>, <string-name name-style="western"><surname>W&#252;rzner</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Kuijper</surname><given-names>EJ</given-names></string-name></person-group>. <year>2003</year>. <article-title>Antibody-dependent killing of meningococci by human neutrophils in serum of late complement component-deficient patients</article-title>. <source>Int Arch Allergy Immunol</source><volume>130</volume>:<fpage>314</fpage>&#8211;<lpage>321</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000070219</pub-id><pub-id pub-id-type="pmid">12740533</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Singh</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Uppuluri</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Mamouei</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Alqarihi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Elhassan</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>French</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lockhart</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Chiller</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Edwards</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Ibrahim</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Gaffen</surname><given-names>SL</given-names></string-name></person-group>. <year>2019</year>. <article-title>The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection</article-title>. <source>PLoS Pathog</source><volume>15</volume>:<elocation-id>e1007460</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1007460</pub-id><pub-id pub-id-type="pmid">31381597</pub-id><pub-id pub-id-type="pmcid">PMC6695204</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mullarkey</surname><given-names>CE</given-names></string-name>, <string-name name-style="western"><surname>Bailey</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Golubeva</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>GS</given-names></string-name>, <string-name name-style="western"><surname>Nachbagauer</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Novakowski</surname><given-names>KE</given-names></string-name>, <string-name name-style="western"><surname>Bowdish</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Palese</surname><given-names>P</given-names></string-name></person-group>. <year>2016</year>. <article-title>Broadly neutralizing hemagglutinin stalk-specific antibodies induce potent phagocytosis of immune complexes by neutrophils in an Fc-dependent manner</article-title>. <source>mBio</source><volume>7</volume>:<elocation-id>e01624-16</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/mBio.01624-16</pub-id><pub-id pub-id-type="pmid">27703076</pub-id><pub-id pub-id-type="pmcid">PMC5050345</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>van den Broek</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>van Els</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Kuipers</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>van Aerde</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Henriet</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>de Groot</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>de Jonge</surname><given-names>MI</given-names></string-name>, <string-name name-style="western"><surname>Langereis</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>van der Flier</surname><given-names>M</given-names></string-name></person-group>. <year>2019</year>. <article-title>Multi-component meningococcal serogroup B (MenB)-4C vaccine induces effective opsonophagocytic killing in children with a complement deficiency</article-title>. <source>Clin Exp Immunol</source><volume>198</volume>:<fpage>381</fpage>&#8211;<lpage>389</lpage>. doi:<pub-id pub-id-type="doi">10.1111/cei.13368</pub-id><pub-id pub-id-type="pmid">31487400</pub-id><pub-id pub-id-type="pmcid">PMC6857189</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kennedy</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Willment</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Dorward</surname><given-names>DW</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>GD</given-names></string-name>, <string-name name-style="western"><surname>DeLeo</surname><given-names>FR</given-names></string-name></person-group>. <year>2007</year>. <article-title>Dectin-1 promotes fungicidal activity of human neutrophils</article-title>. <source>Eur J Immunol</source><volume>37</volume>:<fpage>467</fpage>&#8211;<lpage>478</lpage>. doi:<pub-id pub-id-type="doi">10.1002/eji.200636653</pub-id><pub-id pub-id-type="pmid">17230442</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Barouch</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Broge</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Linde</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ackerman</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>EP</given-names></string-name>, <string-name name-style="western"><surname>Borducchi</surname><given-names>EN</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Nkolola</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2015</year>. <article-title>Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys</article-title>. <source>Science</source><volume>349</volume>:<fpage>320</fpage>&#8211;<lpage>324</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aab3886</pub-id><pub-id pub-id-type="pmid">26138104</pub-id><pub-id pub-id-type="pmcid">PMC4653134</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ackerman</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Mikhailova</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>EP</given-names></string-name>, <string-name name-style="western"><surname>Dowell</surname><given-names>KG</given-names></string-name>, <string-name name-style="western"><surname>Walker</surname><given-names>BD</given-names></string-name>, <string-name name-style="western"><surname>Bailey-Kellogg</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Suscovich</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2016</year>. <article-title>Polyfunctional HIV-specific antibody responses are associated with spontaneous HIV control</article-title>. <source>PLoS Pathog</source><volume>12</volume>:<elocation-id>e1005315</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1005315</pub-id><pub-id pub-id-type="pmid">26745376</pub-id><pub-id pub-id-type="pmcid">PMC4706315</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Forthal</surname><given-names>DN</given-names></string-name>, <string-name name-style="western"><surname>Landucci</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Bream</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jacobson</surname><given-names>LP</given-names></string-name>, <string-name name-style="western"><surname>Phan</surname><given-names>TB</given-names></string-name>, <string-name name-style="western"><surname>Montoya</surname><given-names>B</given-names></string-name></person-group>. <year>2007</year>. <article-title>Fc&#947;RIIa genotype predicts progression of HIV infection</article-title>. <source>J Immunol</source><volume>179</volume>:<fpage>7916</fpage>&#8211;<lpage>7923</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.179.11.7916</pub-id><pub-id pub-id-type="pmid">18025239</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gunn</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Slein</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Ilinykh</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Atyeo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Schendel</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cain</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Roy</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Suscovich</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Takada</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Halfmann</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Kawaoka</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Pauthner</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Momoh</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Goba</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kanneh</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Andersen</surname><given-names>KG</given-names></string-name>, <string-name name-style="western"><surname>Schieffelin</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Grant</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Garry</surname><given-names>RF</given-names></string-name>, <string-name name-style="western"><surname>Saphire</surname><given-names>EO</given-names></string-name>, <string-name name-style="western"><surname>Bukreyev</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2021</year>. <article-title>A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus</article-title>. <source>Immunity</source><volume>54</volume>:<fpage>815</fpage>&#8211;<lpage>828</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2021.03.009</pub-id><pub-id pub-id-type="pmid">33852832</pub-id><pub-id pub-id-type="pmcid">PMC8111768</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Saphire</surname><given-names>EO</given-names></string-name>, <string-name name-style="western"><surname>Schendel</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Gunn</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Milligan</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2018</year>. <article-title>Antibody-mediated protection against Ebola virus</article-title>. <source>Nat Immunol</source><volume>19</volume>:<fpage>1169</fpage>&#8211;<lpage>1178</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41590-018-0233-9</pub-id><pub-id pub-id-type="pmid">30333617</pub-id><pub-id pub-id-type="pmcid">PMC6814399</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pallesen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Murin</surname><given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>de Val</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Cottrell</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Hastie</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Turner</surname><given-names>HL</given-names></string-name>, <string-name name-style="western"><surname>Fusco</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Flyak</surname><given-names>AI</given-names></string-name>, <string-name name-style="western"><surname>Zeitlin</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Crowe</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Andersen</surname><given-names>KG</given-names></string-name>, <string-name name-style="western"><surname>Saphire</surname><given-names>EO</given-names></string-name>, <string-name name-style="western"><surname>Ward</surname><given-names>AB</given-names></string-name></person-group>. <year>2016</year>. <article-title>Structures of Ebola virus GP and sGP in complex with therapeutic antibodies</article-title>. <source>Nat Microbiol</source><volume>1</volume>:<fpage>16128</fpage>. doi:<pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.128</pub-id><pub-id pub-id-type="pmid">27562261</pub-id><pub-id pub-id-type="pmcid">PMC5003320</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Henao-Restrepo</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Camacho</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Longini</surname><given-names>IM</given-names></string-name>, <string-name name-style="western"><surname>Watson</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Edmunds</surname><given-names>WJ</given-names></string-name>, <string-name name-style="western"><surname>Egger</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Carroll</surname><given-names>MW</given-names></string-name>, <string-name name-style="western"><surname>Dean</surname><given-names>NE</given-names></string-name>, <string-name name-style="western"><surname>Diatta</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Doumbia</surname><given-names>M</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2017</year>. <article-title>Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola &#199;a Suffit!)</article-title>. <source>Lancet</source><volume>389</volume>:<fpage>505</fpage>&#8211;<lpage>518</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(16)32621-6</pub-id><pub-id pub-id-type="pmid">28017403</pub-id><pub-id pub-id-type="pmcid">PMC5364328</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mackin</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Desai</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Whitener</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Karl</surname><given-names>CE</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Baric</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Edwards</surname><given-names>DK</given-names></string-name>, <string-name name-style="western"><surname>Chicz</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>McNamara</surname><given-names>RP</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Diamond</surname><given-names>MS</given-names></string-name></person-group>. <year>2023</year>. <article-title>Fc-&#947;R-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2</article-title>. <source>Nat Microbiol</source><volume>8</volume>:<fpage>569</fpage>&#8211;<lpage>580</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41564-023-01359-1</pub-id><pub-id pub-id-type="pmid">37012355</pub-id><pub-id pub-id-type="pmcid">PMC10797606</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Adams</surname><given-names>LE</given-names></string-name>, <string-name name-style="western"><surname>Leist</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Dinnon</surname><given-names>KH</given-names></string-name>, <string-name name-style="western"><surname>West</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gully</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Loome</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Madden</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Powers</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Sch&#228;fer</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sarkar</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Castillo</surname><given-names>IN</given-names></string-name>, <string-name name-style="western"><surname>Maron</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>McNamara</surname><given-names>RP</given-names></string-name>, <string-name name-style="western"><surname>Bertera</surname><given-names>HL</given-names></string-name>, <string-name name-style="western"><surname>Zweigert</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Higgins</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Hampton</surname><given-names>BK</given-names></string-name>, <string-name name-style="western"><surname>Premkumar</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Montgomery</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Baxter</surname><given-names>VK</given-names></string-name>, <string-name name-style="western"><surname>Heise</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>Baric</surname><given-names>RS</given-names></string-name></person-group>. <year>2023</year>. <article-title>Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination</article-title>. <source>Cell Rep</source><volume>42</volume>:<fpage>112326</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2023.112326</pub-id><pub-id pub-id-type="pmid">37000623</pub-id><pub-id pub-id-type="pmcid">PMC10063157</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kaplonek</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Cizmeci</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Fischinger</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Collier</surname><given-names>A-R</given-names></string-name>, <string-name name-style="western"><surname>Suscovich</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Linde</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Broge</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Mann</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Amanat</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Dayal</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Rhee</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>de St Aubin</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Nilles</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Musk</surname><given-names>ER</given-names></string-name>, <string-name name-style="western"><surname>Menon</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Saphire</surname><given-names>EO</given-names></string-name>, <string-name name-style="western"><surname>Krammer</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Lauffenburger</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Barouch</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2022</year>. <article-title>mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions</article-title>. <source>Sci Transl Med</source><volume>14</volume>:<elocation-id>eabm2311</elocation-id>. doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.abm2311</pub-id><pub-id pub-id-type="pmid">35348368</pub-id><pub-id pub-id-type="pmcid">PMC8995030</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Beaudoin-Bussi&#232;res</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Ullah</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Pr&#233;vost</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Tolbert</surname><given-names>WD</given-names></string-name>, <string-name name-style="western"><surname>Symmes</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ding</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Benlarbi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Gong</surname><given-names>SY</given-names></string-name>, <string-name name-style="western"><surname>Tauzin</surname><given-names>A</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2022</year>. <article-title>A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection</article-title>. <source>Cell Rep</source><volume>38</volume>:<fpage>110368</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2022.110368</pub-id><pub-id pub-id-type="pmid">35123652</pub-id><pub-id pub-id-type="pmcid">PMC8786652</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bowman</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Stein</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Shin</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ferbas</surname><given-names>KG</given-names></string-name>, <string-name name-style="western"><surname>Tobin</surname><given-names>NH</given-names></string-name>, <string-name name-style="western"><surname>Mann</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Fischinger</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ollmann Saphire</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Lauffenburger</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Rimoin</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Aldrovandi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2022</year>. <article-title>Hybrid immunity shifts the Fc-effector quality of SARS-CoV-2 mRNA vaccine-induced immunity</article-title>. <source>mBio</source><volume>13</volume>:<elocation-id>e0164722</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/mbio.01647-22</pub-id><pub-id pub-id-type="pmid">36000735</pub-id><pub-id pub-id-type="pmcid">PMC9600672</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Garcia-Beltran</surname><given-names>WF</given-names></string-name>, <string-name name-style="western"><surname>Lam</surname><given-names>EC</given-names></string-name>, <string-name name-style="western"><surname>Astudillo</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>TE</given-names></string-name>, <string-name name-style="western"><surname>Feldman</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hauser</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Caradonna</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Clayton</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Nitido</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Murali</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Charles</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Dighe</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Branda</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Lennerz</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Lingwood</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Schmidt</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Iafrate</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Balazs</surname><given-names>AB</given-names></string-name></person-group>. <year>2021</year>. <article-title>COVID-19-neutralizing antibodies predict disease severity and survival</article-title>. <source>Cell</source><volume>184</volume>:<fpage>476</fpage>&#8211;<lpage>488</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2020.12.015</pub-id><pub-id pub-id-type="pmid">33412089</pub-id><pub-id pub-id-type="pmcid">PMC7837114</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zohar</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Loos</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Fischinger</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Atyeo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Slein</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Burke</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Feldman</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hauser</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Caradonna</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Schmidt</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Cai</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Streeck</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ryan</surname><given-names>ET</given-names></string-name>, <string-name name-style="western"><surname>Barouch</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Charles</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Lauffenburger</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2020</year>. <article-title>Compromised humoral functional evolution tracks with SARS-CoV-2 mortality</article-title>. <source>Cell</source><volume>183</volume>:<fpage>1508</fpage>&#8211;<lpage>1519</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2020.10.052</pub-id><pub-id pub-id-type="pmid">33207184</pub-id><pub-id pub-id-type="pmcid">PMC7608014</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Suscovich</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Fallon</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Das</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Demas</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Crain</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Linde</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Michell</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Natarajan</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Arevalo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Broge</surname><given-names>T</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2020</year>. <article-title>Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccination</article-title>. <source>Sci Transl Med</source><volume>12</volume>:<elocation-id>eabb4757</elocation-id>. doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.abb4757</pub-id><pub-id pub-id-type="pmid">32718991</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Regules</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Cicatelli</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Bennett</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Paolino</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Twomey</surname><given-names>PS</given-names></string-name>, <string-name name-style="western"><surname>Moon</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Kathcart</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Hauns</surname><given-names>KD</given-names></string-name>, <string-name name-style="western"><surname>Komisar</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Qabar</surname><given-names>AN</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2016</year>. <article-title>Fractional third and fourth dose of RTS,S/AS01 malaria candidate vaccine: a phase 2a controlled human malaria parasite infection and immunogenicity study</article-title>. <source>J Infect Dis</source><volume>214</volume>:<fpage>762</fpage>&#8211;<lpage>771</lpage>. doi:<pub-id pub-id-type="doi">10.1093/infdis/jiw237</pub-id><pub-id pub-id-type="pmid">27296848</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>RTS,S Clinical Trials Partnership</collab></person-group>. <year>2015</year>. <article-title>Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial</article-title>. <source>Lancet</source><volume>386</volume>:<fpage>31</fpage>&#8211;<lpage>45</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(15)60721-8</pub-id><pub-id pub-id-type="pmid">25913272</pub-id><pub-id pub-id-type="pmcid">PMC5626001</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lohse</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Loew</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kretschmer</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Jansen</surname><given-names>JHM</given-names></string-name>, <string-name name-style="western"><surname>Meyer</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ten Broeke</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>R&#246;sner</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Dechant</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Derer</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Klausz</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kellner</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Schwanbeck</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>French</surname><given-names>RR</given-names></string-name>, <string-name name-style="western"><surname>Tipton</surname><given-names>TRW</given-names></string-name>, <string-name name-style="western"><surname>Cragg</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Schewe</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Peipp</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Leusen</surname><given-names>JHW</given-names></string-name>, <string-name name-style="western"><surname>Valerius</surname><given-names>T</given-names></string-name></person-group>. <year>2018</year>. <article-title>Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity</article-title>. <source>Br J Haematol</source><volume>181</volume>:<fpage>413</fpage>&#8211;<lpage>417</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bjh.14624</pub-id><pub-id pub-id-type="pmid">28449349</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Karagiannis</surname><given-names>SN</given-names></string-name>, <string-name name-style="western"><surname>Josephs</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Karagiannis</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Gilbert</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Saul</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Rudman</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Dodev</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Koers</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Blower</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Corrigan</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Beavil</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Spicer</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Nestle</surname><given-names>FO</given-names></string-name>, <string-name name-style="western"><surname>Gould</surname><given-names>HJ</given-names></string-name></person-group>. <year>2012</year>. <article-title>Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application</article-title>. <source>Cancer Immunol Immunother</source><volume>61</volume>:<fpage>1547</fpage>&#8211;<lpage>1564</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00262-011-1162-8</pub-id><pub-id pub-id-type="pmid">22139135</pub-id><pub-id pub-id-type="pmcid">PMC11028906</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jin</surname><given-names>BR</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Jang</surname><given-names>YS</given-names></string-name>, <string-name name-style="western"><surname>Seo</surname><given-names>GY</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>PH</given-names></string-name></person-group>. <year>2013</year>. <article-title>Alum directly modulates murine B lymphocytes to produce IgG1 Isotype</article-title>. <source>Immune Netw</source><volume>13</volume>:<fpage>10</fpage>&#8211;<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.4110/in.2013.13.1.10</pub-id><pub-id pub-id-type="pmid">23559895</pub-id><pub-id pub-id-type="pmcid">PMC3607705</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>He</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Liang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Hong</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ruan</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Shao</surname><given-names>Y</given-names></string-name></person-group>. <year>2013</year>. <article-title>The potential role of CD16+ V&#947;2V&#948;2 T cell-mediated antibody-dependent cell-mediated cytotoxicity in control of HIV type 1 disease</article-title>. <source>AIDS Res Hum Retroviruses</source><volume>29</volume>:<fpage>1562</fpage>&#8211;<lpage>1570</lpage>. doi:<pub-id pub-id-type="doi">10.1089/AID.2013.0111</pub-id><pub-id pub-id-type="pmid">23957587</pub-id><pub-id pub-id-type="pmcid">PMC3848486</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vanderven</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Ana-Sosa-Batiz</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Nguyen</surname><given-names>TH</given-names></string-name>, <string-name name-style="western"><surname>Wan</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wines</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Hogarth</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Tilmanis</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Reynaldi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Parsons</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Hurt</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Davenport</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Kotsimbos</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Kedzierska</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kent</surname><given-names>SJ</given-names></string-name></person-group>. <year>2017</year>. <article-title>Fc functional antibodies in humans with severe H7N9 and seasonal influenza</article-title>. <source>JCI Insight</source><volume>2</volume>:<elocation-id>e92750</elocation-id>. doi:<pub-id pub-id-type="doi">10.1172/jci.insight.92750</pub-id><pub-id pub-id-type="pmid">28679958</pub-id><pub-id pub-id-type="pmcid">PMC5499372</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Larra&#241;aga</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Ampuero</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Luchsinger</surname><given-names>VF</given-names></string-name>, <string-name name-style="western"><surname>Carri&#243;n</surname><given-names>FA</given-names></string-name>, <string-name name-style="western"><surname>Aguilar</surname><given-names>NV</given-names></string-name>, <string-name name-style="western"><surname>Morales</surname><given-names>PR</given-names></string-name>, <string-name name-style="western"><surname>Palomino</surname><given-names>MAM</given-names></string-name>, <string-name name-style="western"><surname>Tapia</surname><given-names>LF</given-names></string-name>, <string-name name-style="western"><surname>Avenda&#241;o</surname><given-names>LF</given-names></string-name></person-group>. <year>2009</year>. <article-title>Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus</article-title>. <source>Pediatr Infect Dis J</source><volume>28</volume>:<fpage>867</fpage>&#8211;<lpage>873</lpage>. doi:<pub-id pub-id-type="doi">10.1097/INF.0b013e3181a3ea71</pub-id><pub-id pub-id-type="pmid">19738511</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Saphire</surname><given-names>EO</given-names></string-name>, <string-name name-style="western"><surname>Schendel</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Fusco</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Gangavarapu</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Gunn</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Wec</surname><given-names>AZ</given-names></string-name>, <string-name name-style="western"><surname>Halfmann</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Brannan</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Herbert</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Qiu</surname><given-names>X</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2018</year>. <article-title>Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection</article-title>. <source>Cell</source><volume>174</volume>:<fpage>938</fpage>&#8211;<lpage>952</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2018.07.033</pub-id><pub-id pub-id-type="pmid">30096313</pub-id><pub-id pub-id-type="pmcid">PMC6102396</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>DiLillo</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>GS</given-names></string-name>, <string-name name-style="western"><surname>Palese</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></string-name></person-group>. <year>2014</year>. <article-title>Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc&#947;R interactions for protection against influenza virus in vivo</article-title>. <source>Nat Med</source><volume>20</volume>:<fpage>143</fpage>&#8211;<lpage>151</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nm.3443</pub-id><pub-id pub-id-type="pmid">24412922</pub-id><pub-id pub-id-type="pmcid">PMC3966466</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Garand</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Goodier</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Owolabi</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Donkor</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kampmann</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Sutherland</surname><given-names>JS</given-names></string-name></person-group>. <year>2018</year>. <article-title>Functional and phenotypic changes of natural killer cells in whole blood during Mycobacterium tuberculosis infection and disease</article-title>. <source>Front Immunol</source><volume>9</volume>:<fpage>257</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2018.00257</pub-id><pub-id pub-id-type="pmid">29520269</pub-id><pub-id pub-id-type="pmcid">PMC5827559</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lu</surname><given-names>LL</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Rosebrock</surname><given-names>TR</given-names></string-name>, <string-name name-style="western"><surname>Ghebremichael</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>WH</given-names></string-name>, <string-name name-style="western"><surname>Grace</surname><given-names>PS</given-names></string-name>, <string-name name-style="western"><surname>Schoen</surname><given-names>MK</given-names></string-name>, <string-name name-style="western"><surname>Tafesse</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Martin</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Leung</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Mahan</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Sips</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kumar</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Tedesco</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Robinson</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Tkachenko</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Draghi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Freedberg</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Streeck</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Suscovich</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Lauffenburger</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Restrepo</surname><given-names>BI</given-names></string-name>, <string-name name-style="western"><surname>Day</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Fortune</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2016</year>. <article-title>A functional role for antibodies in tuberculosis</article-title>. <source>Cell</source><volume>167</volume>:<fpage>433</fpage>&#8211;<lpage>443</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2016.08.072</pub-id><pub-id pub-id-type="pmid">27667685</pub-id><pub-id pub-id-type="pmcid">PMC5526202</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chen</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Amaladoss</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ye</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Dummler</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kong</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Wong</surname><given-names>LH</given-names></string-name>, <string-name name-style="western"><surname>Loo</surname><given-names>HL</given-names></string-name>, <string-name name-style="western"><surname>Loh</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>SQ</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>TC</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>KTE</given-names></string-name>, <string-name name-style="western"><surname>Dao</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Suresh</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Preiser</surname><given-names>PR</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>J</given-names></string-name></person-group>. <year>2014</year>. <article-title>Human natural killer cells control Plasmodium falciparum infection by eliminating infected red blood cells</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>111</volume>:<fpage>1479</fpage>&#8211;<lpage>1484</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1323318111</pub-id><pub-id pub-id-type="pmid">24474774</pub-id><pub-id pub-id-type="pmcid">PMC3910619</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>White</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>Bejon</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Olotu</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Griffin</surname><given-names>JT</given-names></string-name>, <string-name name-style="western"><surname>Riley</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Kester</surname><given-names>KE</given-names></string-name>, <string-name name-style="western"><surname>Ockenhouse</surname><given-names>CF</given-names></string-name>, <string-name name-style="western"><surname>Ghani</surname><given-names>AC</given-names></string-name></person-group>. <year>2013</year>. <article-title>The relationship between RTS,S vaccine-induced antibodies, CD4<sup>+</sup> T cell responses and protection against Plasmodium falciparum infection</article-title>. <source>PLoS One</source><volume>8</volume>:<elocation-id>e61395</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0061395</pub-id><pub-id pub-id-type="pmid">23613845</pub-id><pub-id pub-id-type="pmcid">PMC3628884</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lieke</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Steeg</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Graefe</surname><given-names>SEB</given-names></string-name>, <string-name name-style="western"><surname>Fleischer</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Jacobs</surname><given-names>T</given-names></string-name></person-group>. <year>2006</year>. <article-title>Interaction of natural killer cells with Trypanosoma cruzi-infected fibroblasts</article-title>. <source>Clin Exp Immunol</source><volume>145</volume>:<fpage>357</fpage>&#8211;<lpage>364</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2249.2006.03118.x</pub-id><pub-id pub-id-type="pmid">16879257</pub-id><pub-id pub-id-type="pmcid">PMC1809687</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ricklin</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Hajishengallis</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lambris</surname><given-names>JD</given-names></string-name></person-group>. <year>2010</year>. <article-title>Complement: a key system for immune surveillance and homeostasis</article-title>. <source>Nat Immunol</source><volume>11</volume>:<fpage>785</fpage>&#8211;<lpage>797</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ni.1923</pub-id><pub-id pub-id-type="pmid">20720586</pub-id><pub-id pub-id-type="pmcid">PMC2924908</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Saifuddin</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hedayati</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Atkinson</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Holguin</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Parker</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Spear</surname><given-names>GT</given-names></string-name></person-group>. <year>1997</year>. <article-title>Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction</article-title>. <source>J Gen Virol</source><volume>78 ( Pt 8)</volume>:<fpage>1907</fpage>&#8211;<lpage>1911</lpage>. doi:<pub-id pub-id-type="doi">10.1099/0022-1317-78-8-1907</pub-id><pub-id pub-id-type="pmid">9266986</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vanderplasschen</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mathew</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Hollinshead</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sim</surname><given-names>RB</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>GL</given-names></string-name></person-group>. <year>1998</year>. <article-title>Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>95</volume>:<fpage>7544</fpage>&#8211;<lpage>7549</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.95.13.7544</pub-id><pub-id pub-id-type="pmid">9636186</pub-id><pub-id pub-id-type="pmcid">PMC22678</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Benhnia</surname><given-names>M-E-I</given-names></string-name>, <string-name name-style="western"><surname>McCausland</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Laudenslager</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Granger</surname><given-names>SW</given-names></string-name>, <string-name name-style="western"><surname>Rickert</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Koriazova</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Tahara</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kubo</surname><given-names>RT</given-names></string-name>, <string-name name-style="western"><surname>Kato</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Crotty</surname><given-names>S</given-names></string-name></person-group>. <year>2009</year>. <article-title>Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5</article-title>. <source>J Virol</source><volume>83</volume>:<fpage>12355</fpage>&#8211;<lpage>12367</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JVI.01593-09</pub-id><pub-id pub-id-type="pmid">19793826</pub-id><pub-id pub-id-type="pmcid">PMC2786738</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jang</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Sahastrabuddhe</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Yun</surname><given-names>C-H</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>JS</given-names></string-name></person-group>. <year>2016</year>. <article-title>Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method</article-title>. <source>Microb Pathog</source><volume>97</volume>:<fpage>19</fpage>&#8211;<lpage>26</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.micpath.2016.05.013</pub-id><pub-id pub-id-type="pmid">27216239</pub-id><pub-id pub-id-type="pmcid">PMC4944902</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nahm</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Weerts</surname><given-names>HP</given-names></string-name>, <string-name name-style="western"><surname>Wenzel</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Tamilselvi</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Chandrasekaran</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Pasetti</surname><given-names>MF</given-names></string-name>, <string-name name-style="western"><surname>Mani</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kaminski</surname><given-names>RW</given-names></string-name></person-group>. <year>2018</year>. <article-title>Development, interlaboratory evaluations, and application of a simple, high-throughput Shigella serum bactericidal assay</article-title>. <source>mSphere</source><volume>3</volume>:<elocation-id>e00146-18</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/mSphere.00146-18</pub-id><pub-id pub-id-type="pmid">29898979</pub-id><pub-id pub-id-type="pmcid">PMC6001606</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mehlhop</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Diamond</surname><given-names>MS</given-names></string-name></person-group>. <year>2006</year>. <article-title>Protective immune responses against West Nile virus are primed by distinct complement activation pathways</article-title>. <source>J Exp Med</source><volume>203</volume>:<fpage>1371</fpage>&#8211;<lpage>1381</lpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.20052388</pub-id><pub-id pub-id-type="pmid">16651386</pub-id><pub-id pub-id-type="pmcid">PMC2121216</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Huber</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Fischer</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Misselwitz</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Manrique</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kuster</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Nieder&#246;st</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Weber</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>von Wyl</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>G&#252;nthard</surname><given-names>HF</given-names></string-name>, <string-name name-style="western"><surname>Trkola</surname><given-names>A</given-names></string-name></person-group>. <year>2006</year>. <article-title>Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection</article-title>. <source>PLoS Med</source><volume>3</volume>:<elocation-id>e441</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pmed.0030441</pub-id><pub-id pub-id-type="pmid">17121450</pub-id><pub-id pub-id-type="pmcid">PMC1637124</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Benhnia</surname><given-names>M-E-I</given-names></string-name>, <string-name name-style="western"><surname>McCausland</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Moyron</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Laudenslager</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Granger</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Rickert</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Koriazova</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Kubo</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Kato</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Crotty</surname><given-names>S</given-names></string-name></person-group>. <year>2009</year>. <article-title>Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement</article-title>. <source>J Virol</source><volume>83</volume>:<fpage>1201</fpage>&#8211;<lpage>1215</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JVI.01797-08</pub-id><pub-id pub-id-type="pmid">19019965</pub-id><pub-id pub-id-type="pmcid">PMC2620895</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Blander</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Barbet</surname><given-names>G</given-names></string-name></person-group>. <year>2018</year>. <article-title>Exploiting vita-PAMPs in vaccines</article-title>. <source>Curr Opin Pharmacol</source><volume>41</volume>:<fpage>128</fpage>&#8211;<lpage>136</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.coph.2018.05.012</pub-id><pub-id pub-id-type="pmid">29890457</pub-id><pub-id pub-id-type="pmcid">PMC6110613</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mosca</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Tritto</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Muzzi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Monaci</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Bagnoli</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Iavarone</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Hagan</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Rappuoli</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>De Gregorio</surname><given-names>E</given-names></string-name></person-group>. <year>2008</year>. <article-title>Molecular and cellular signatures of human vaccine adjuvants</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>105</volume>:<fpage>10501</fpage>&#8211;<lpage>10506</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0804699105</pub-id><pub-id pub-id-type="pmid">18650390</pub-id><pub-id pub-id-type="pmcid">PMC2483233</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Morel</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Didierlaurent</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bourguignon</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Delhaye</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Baras</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Jacob</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Planty</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Elouahabi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Harvengt</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Carlsen</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kielland</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Chomez</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Gar&#231;on</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Van Mechelen</surname><given-names>M</given-names></string-name></person-group>. <year>2011</year>. <article-title>Adjuvant system AS03 containing &#945;-tocopherol modulates innate immune response and leads to improved adaptive immunity</article-title>. <source>Vaccine</source><volume>29</volume>:<fpage>2461</fpage>&#8211;<lpage>2473</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2011.01.011</pub-id><pub-id pub-id-type="pmid">21256188</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sato</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Reuter</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Hiranuma</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Shibata</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Fukui</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Motoi</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Murakami</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Tsukamoto</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yamazaki</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Saitoh</surname><given-names>S-I</given-names></string-name>, <string-name name-style="western"><surname>Latz</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Miyake</surname><given-names>K</given-names></string-name></person-group>. <year>2020</year>. <article-title>The impact of cell maturation and tissue microenvironments on the expression of endosomal toll-like receptors in monocytes and macrophages</article-title>. <source>Int Immunol</source><volume>32</volume>:<fpage>785</fpage>&#8211;<lpage>798</lpage>. doi:<pub-id pub-id-type="doi">10.1093/intimm/dxaa055</pub-id><pub-id pub-id-type="pmid">32840578</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Pasare</surname><given-names>C</given-names></string-name></person-group>. <year>2013</year>. <article-title>Location, location, location: tissue-specific regulation of immune responses</article-title>. <source>J Leukoc Biol</source><volume>94</volume>:<fpage>409</fpage>&#8211;<lpage>421</lpage>. doi:<pub-id pub-id-type="doi">10.1189/jlb.0413207</pub-id><pub-id pub-id-type="pmid">23825388</pub-id><pub-id pub-id-type="pmcid">PMC3747123</pub-id></mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Boyaka</surname><given-names>PN</given-names></string-name></person-group>. <year>2017</year>. <article-title>Inducing mucosal IgA: a challenge for vaccine adjuvants and delivery systems</article-title>. <source>J Immunol</source><volume>199</volume>:<fpage>9</fpage>&#8211;<lpage>16</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.1601775</pub-id><pub-id pub-id-type="pmid">28630108</pub-id><pub-id pub-id-type="pmcid">PMC5719502</pub-id></mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kenney</surname><given-names>RT</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Guebre-Xabier</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Frech</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Lambert</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Heller</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Ellingsworth</surname><given-names>LR</given-names></string-name>, <string-name name-style="western"><surname>Eyles</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Williamson</surname><given-names>ED</given-names></string-name>, <string-name name-style="western"><surname>Glenn</surname><given-names>GM</given-names></string-name></person-group>. <year>2004</year>. <article-title>Induction of protective immunity against lethal anthrax challenge with a patch</article-title>. <source>J Infect Dis</source><volume>190</volume>:<fpage>774</fpage>&#8211;<lpage>782</lpage>. doi:<pub-id pub-id-type="doi">10.1086/422694</pub-id><pub-id pub-id-type="pmid">15272406</pub-id></mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Koutsonanos</surname><given-names>DG</given-names></string-name>, <string-name name-style="western"><surname>del Pilar Martin</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Zarnitsyn</surname><given-names>VG</given-names></string-name>, <string-name name-style="western"><surname>Jacob</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Prausnitz</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Compans</surname><given-names>RW</given-names></string-name>, <string-name name-style="western"><surname>Skountzou</surname><given-names>I</given-names></string-name></person-group>. <year>2011</year>. <article-title>Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination</article-title>. <source>J Infect Dis</source><volume>204</volume>:<fpage>582</fpage>&#8211;<lpage>591</lpage>. doi:<pub-id pub-id-type="doi">10.1093/infdis/jir094</pub-id><pub-id pub-id-type="pmid">21685355</pub-id><pub-id pub-id-type="pmcid">PMC3144165</pub-id></mixed-citation></ref><ref id="B125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sullivan</surname><given-names>SP</given-names></string-name>, <string-name name-style="western"><surname>Koutsonanos</surname><given-names>DG</given-names></string-name>, <string-name name-style="western"><surname>Del Pilar Martin</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Zarnitsyn</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Choi</surname><given-names>SO</given-names></string-name>, <string-name name-style="western"><surname>Murthy</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Compans</surname><given-names>RW</given-names></string-name>, <string-name name-style="western"><surname>Skountzou</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Prausnitz</surname><given-names>MR</given-names></string-name></person-group>. <year>2010</year>. <article-title>Dissolving polymer microneedle patches for influenza vaccination</article-title>. <source>Nat Med</source><volume>16</volume>:<fpage>915</fpage>&#8211;<lpage>920</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nm.2182</pub-id><pub-id pub-id-type="pmid">20639891</pub-id><pub-id pub-id-type="pmcid">PMC2917494</pub-id></mixed-citation></ref><ref id="B126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Koutsonanos</surname><given-names>DG</given-names></string-name>, <string-name name-style="western"><surname>Esser</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>McMaster</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Kalluri</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>J-W</given-names></string-name>, <string-name name-style="western"><surname>Prausnitz</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Skountzou</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Denning</surname><given-names>TL</given-names></string-name>, <string-name name-style="western"><surname>Kohlmeier</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Compans</surname><given-names>RW</given-names></string-name></person-group>. <year>2015</year>. <article-title>Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts</article-title>. <source>Vaccine</source><volume>33</volume>:<fpage>4675</fpage>&#8211;<lpage>4682</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2015.01.086</pub-id><pub-id pub-id-type="pmid">25744228</pub-id><pub-id pub-id-type="pmcid">PMC5757502</pub-id></mixed-citation></ref><ref id="B127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Boonnak</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Dhitavat</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Thantamnu</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Kosoltanapiwat</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Auayporn</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Puthavathana</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Pitisuttithum</surname><given-names>P</given-names></string-name></person-group>. <year>2017</year>. <article-title>Immune responses to intradermal and intramuscular inactivated influenza vaccine among older age group</article-title>. <source>Vaccine</source><volume>35</volume>:<fpage>7339</fpage>&#8211;<lpage>7346</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2017.10.106</pub-id><pub-id pub-id-type="pmid">29157960</pub-id></mixed-citation></ref><ref id="B128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Seder</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>L-J</given-names></string-name>, <string-name name-style="western"><surname>Enama</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Zephir</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Sarwar</surname><given-names>UN</given-names></string-name>, <string-name name-style="western"><surname>Gordon</surname><given-names>IJ</given-names></string-name>, <string-name name-style="western"><surname>Holman</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>James</surname><given-names>ER</given-names></string-name>, <string-name name-style="western"><surname>Billingsley</surname><given-names>PF</given-names></string-name>, <string-name name-style="western"><surname>Gunasekera</surname><given-names>A</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2013</year>. <article-title>Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine</article-title>. <source>Science</source><volume>341</volume>:<fpage>1359</fpage>&#8211;<lpage>1365</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1241800</pub-id><pub-id pub-id-type="pmid">23929949</pub-id></mixed-citation></ref><ref id="B129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Darrah</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Zeppa</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Maiello</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Hackney</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Wadsworth</surname><given-names>MH</given-names><suffix>II</suffix></string-name>, <string-name name-style="western"><surname>Hughes</surname><given-names>TK</given-names></string-name>, <string-name name-style="western"><surname>Pokkali</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Swanson</surname><given-names>PA</given-names><suffix>II</suffix></string-name>, <string-name name-style="western"><surname>Grant</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Rodgers</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Kamath</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Causgrove</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Laddy</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Bonavia</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Casimiro</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>PL</given-names></string-name>, <string-name name-style="western"><surname>Klein</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>White</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Scanga</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Shalek</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Roederer</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Flynn</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Seder</surname><given-names>RA</given-names></string-name></person-group>. <year>2020</year>. <article-title>Prevention of tuberculosis in macaques after intravenous BCG immunization</article-title>. <source>Nature</source><volume>577</volume>:<fpage>95</fpage>&#8211;<lpage>102</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-019-1817-8</pub-id><pub-id pub-id-type="pmid">31894150</pub-id><pub-id pub-id-type="pmcid">PMC7015856</pub-id></mixed-citation></ref><ref id="B130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bartsch</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>St Denis</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Kaplonek</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lam</surname><given-names>EC</given-names></string-name>, <string-name name-style="western"><surname>Burns</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Farkas</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Boribong</surname><given-names>BP</given-names></string-name>, <string-name name-style="western"><surname>Edlow</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Fasano</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Shreffler</surname><given-names>WG</given-names></string-name>, <string-name name-style="western"><surname>Zavadska</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Goldblatt</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Balazs</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Yonker</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2022</year>. <article-title>SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children</article-title>. <source>Sci Transl Med</source><volume>14</volume>:<elocation-id>eabn9237</elocation-id>. doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.abn9237</pub-id><pub-id pub-id-type="pmid">35881018</pub-id><pub-id pub-id-type="pmcid">PMC9348753</pub-id></mixed-citation></ref><ref id="B131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Atyeo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>DeRiso</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Bordt</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>De Guzman</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Shook</surname><given-names>LL</given-names></string-name>, <string-name name-style="western"><surname>Yonker</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Fasano</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Akinwunmi</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Lauffenburger</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Elovitz</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Gray</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Edlow</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2021</year>. <article-title>COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women</article-title>. <source>Sci Transl Med</source><volume>13</volume>:<elocation-id>eabi8631</elocation-id>. doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.abi8631</pub-id><pub-id pub-id-type="pmid">34664972</pub-id><pub-id pub-id-type="pmcid">PMC9067624</pub-id></mixed-citation></ref><ref id="B132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gunn</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>McNamara</surname><given-names>RP</given-names></string-name>, <string-name name-style="western"><surname>Wood</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Taylor</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Devadhasan</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Das</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Nilsson</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Shurtleff</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Dubey</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Eichberg</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Suscovich</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Saphire</surname><given-names>EO</given-names></string-name>, <string-name name-style="western"><surname>Lauffenburger</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Coller</surname><given-names>B-A</given-names></string-name>, <string-name name-style="western"><surname>Simon</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2023</year>. <article-title>Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates</article-title>. <source>Cell Rep</source><volume>42</volume>:<fpage>112402</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2023.112402</pub-id><pub-id pub-id-type="pmid">37061918</pub-id><pub-id pub-id-type="pmcid">PMC10576837</pub-id></mixed-citation></ref><ref id="B133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bartsch</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>Tong</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Avenda&#241;o</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Serrano</surname><given-names>EF</given-names></string-name>, <string-name name-style="western"><surname>Garc&#237;a-Salum</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Pardo-Roa</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Riquelme</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Cai</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Renzi</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Stewart-Jones</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Medina</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2022</year>. <article-title>Omicron variant spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines</article-title>. <source>Sci Transl Med</source><volume>14</volume>:<elocation-id>eabn9243</elocation-id>. doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.abn9243</pub-id><pub-id pub-id-type="pmid">35289637</pub-id><pub-id pub-id-type="pmcid">PMC8995028</pub-id></mixed-citation></ref><ref id="B134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gorman</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Guebre-Xabier</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Atyeo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Pullen</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Loos</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Goez-Gazi</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Carrion</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Tian</surname><given-names>JH</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2021</year>. <article-title>Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with matrix-M vaccination</article-title>. <source>Cell Rep Med</source><volume>2</volume>:<elocation-id>100405</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.xcrm.2021.100405</pub-id><pub-id pub-id-type="pmid">34485950</pub-id><pub-id pub-id-type="pmcid">PMC8405506</pub-id></mixed-citation></ref><ref id="B135"><label>135</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Francica</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Flynn</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Foulds</surname><given-names>KE</given-names></string-name>, <string-name name-style="western"><surname>Noe</surname><given-names>AT</given-names></string-name>, <string-name name-style="western"><surname>Werner</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Moore</surname><given-names>IN</given-names></string-name>, <string-name name-style="western"><surname>Gagne</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Johnston</surname><given-names>TS</given-names></string-name>, <string-name name-style="western"><surname>Tucker</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>RL</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2021</year>. <article-title>Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates</article-title>. <source>Sci Transl Med</source><volume>13</volume>. doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.abi4547</pub-id><pub-id pub-id-type="pmcid">PMC9266840</pub-id><pub-id pub-id-type="pmid">34315825</pub-id></mixed-citation></ref><ref id="B136"><label>136</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hassan</surname><given-names>AO</given-names></string-name>, <string-name name-style="western"><surname>Shrihari</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gorman</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Ying</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Yuan</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Raju</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>RE</given-names></string-name>, <string-name name-style="western"><surname>Dmitriev</surname><given-names>IP</given-names></string-name>, <string-name name-style="western"><surname>Kashentseva</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Adams</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Mann</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Davis-Gardner</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Suthar</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>P-Y</given-names></string-name>, <string-name name-style="western"><surname>Saphire</surname><given-names>EO</given-names></string-name>, <string-name name-style="western"><surname>Fremont</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Curiel</surname><given-names>DT</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Diamond</surname><given-names>MS</given-names></string-name></person-group>. <year>2021</year>. <article-title>An intranasal vaccine durably protects against SARS-CoV-2 variants in mice</article-title>. <source>Cell Rep</source><volume>36</volume>:<fpage>109452</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2021.109452</pub-id><pub-id pub-id-type="pmid">34289385</pub-id><pub-id pub-id-type="pmcid">PMC8270739</pub-id></mixed-citation></ref><ref id="B137"><label>137</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kasturi</surname><given-names>SP</given-names></string-name>, <string-name name-style="western"><surname>Skountzou</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Albrecht</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Koutsonanos</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Hua</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Nakaya</surname><given-names>HI</given-names></string-name>, <string-name name-style="western"><surname>Ravindran</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Stewart</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Alam</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kwissa</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Villinger</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Murthy</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Steel</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jacob</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hogan</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Garc&#237;a-Sastre</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Compans</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Pulendran</surname><given-names>B</given-names></string-name></person-group>. <year>2011</year>. <article-title>Programming the magnitude and persistence of antibody responses with innate immunity</article-title>. <source>Nature</source><volume>470</volume>:<fpage>543</fpage>&#8211;<lpage>547</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature09737</pub-id><pub-id pub-id-type="pmid">21350488</pub-id><pub-id pub-id-type="pmcid">PMC3057367</pub-id></mixed-citation></ref><ref id="B138"><label>138</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ko</surname><given-names>E-J</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>Y-T</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>K-H</given-names></string-name>, <string-name name-style="western"><surname>Jung</surname><given-names>Y-J</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Denning</surname><given-names>TL</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname><given-names>S-M</given-names></string-name></person-group>. <year>2016</year>. <article-title>Effects of MF59 adjuvant on induction of isotype-switched IgG antibodies and protection after immunization with T-dependent influenza virus vaccine in the absence of CD4<sup>+</sup> T cells</article-title>. <source>J Virol</source><volume>90</volume>:<fpage>6976</fpage>&#8211;<lpage>6988</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JVI.00339-16</pub-id><pub-id pub-id-type="pmid">27226368</pub-id><pub-id pub-id-type="pmcid">PMC4944285</pub-id></mixed-citation></ref><ref id="B139"><label>139</label><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name name-style="western"><surname>Luo</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Gordy</surname><given-names>JT</given-names></string-name>, <string-name name-style="western"><surname>Zavala</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Markham</surname><given-names>RB</given-names></string-name></person-group>. <year>2020</year>. <article-title>A vaccine composed of antigen fused to a ligand for a receptor on immature dendritic cells elicits elevated antibody responses to malaria sporozoites in infant macaques</article-title>. <source>bioRxiv</source>. doi:<pub-id pub-id-type="doi">10.1101/530840</pub-id><pub-id pub-id-type="pmcid">PMC7807052</pub-id><pub-id pub-id-type="pmid">33441615</pub-id></mixed-citation></ref><ref id="B140"><label>140</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Boudreau</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>WH</given-names></string-name>, <string-name name-style="western"><surname>Suscovich</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Talbot</surname><given-names>HK</given-names></string-name>, <string-name name-style="western"><surname>Edwards</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2020</year>. <article-title>Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination</article-title>. <source>J Clin Invest</source><volume>130</volume>:<fpage>662</fpage>&#8211;<lpage>672</lpage>. doi:<pub-id pub-id-type="doi">10.1172/JCI129520</pub-id><pub-id pub-id-type="pmid">31845904</pub-id><pub-id pub-id-type="pmcid">PMC6994146</pub-id></mixed-citation></ref><ref id="B141"><label>141</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Corbett</surname><given-names>KS</given-names></string-name>, <string-name name-style="western"><surname>Nason</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Flach</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Gagne</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Connell</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Johnston</surname><given-names>TS</given-names></string-name>, <string-name name-style="western"><surname>Shah</surname><given-names>SN</given-names></string-name>, <string-name name-style="western"><surname>Edara</surname><given-names>VV</given-names></string-name>, <string-name name-style="western"><surname>Floyd</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lai</surname><given-names>L</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2021</year>. <article-title>Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates</article-title>. <source>Science</source><volume>373</volume>:<elocation-id>eabj0299</elocation-id>. doi:<pub-id pub-id-type="doi">10.1126/science.abj0299</pub-id><pub-id pub-id-type="pmid">34529476</pub-id><pub-id pub-id-type="pmcid">PMC8449013</pub-id></mixed-citation></ref><ref id="B142"><label>142</label><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name name-style="western"><surname>de Bruyn</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Purvis</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ruiz</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Adhikarla</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Alvi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bonaparte</surname><given-names>MI</given-names></string-name>, <string-name name-style="western"><surname>Brune</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Bueso</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Canter</surname><given-names>RM</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2022</year>. <article-title>Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines</article-title>. <source>Cold Spring Harbor Laboratory, MedRXiv</source>. doi:<pub-id pub-id-type="doi">10.1101/2022.12.02.22282931</pub-id><pub-id pub-id-type="pmcid">PMC10391925</pub-id><pub-id pub-id-type="pmid">37533419</pub-id></mixed-citation></ref><ref id="B143"><label>143</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pavot</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Berry</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Kishko</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Anosova</surname><given-names>NG</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Tibbitts</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Raillard</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gautheron</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gutzeit</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Koutsoukos</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Chicz</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Lecouturier</surname><given-names>V</given-names></string-name></person-group>. <year>2022</year>. <article-title>Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates</article-title>. <source>Nat Commun</source><volume>13</volume>:<fpage>1699</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-022-29219-2</pub-id><pub-id pub-id-type="pmid">35361754</pub-id><pub-id pub-id-type="pmcid">PMC8971430</pub-id></mixed-citation></ref><ref id="B144"><label>144</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kumar</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Anselmo</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Banerjee</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Zakrewsky</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Mitragotri</surname><given-names>S</given-names></string-name></person-group>. <year>2015</year>. <article-title>Shape and size-dependent immune response to antigen-carrying nanoparticles</article-title>. <source>J Control Release</source><volume>220</volume>:<fpage>141</fpage>&#8211;<lpage>148</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jconrel.2015.09.069</pub-id><pub-id pub-id-type="pmid">26437263</pub-id></mixed-citation></ref><ref id="B145"><label>145</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Slifka</surname><given-names>MK</given-names></string-name>, <string-name name-style="western"><surname>Amanna</surname><given-names>IJ</given-names></string-name></person-group>. <year>2019</year>. <article-title>Role of multivalency and antigenic threshold in generating protective antibody responses</article-title>. <source>Front Immunol</source><volume>10</volume>:<fpage>956</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2019.00956</pub-id><pub-id pub-id-type="pmid">31118935</pub-id><pub-id pub-id-type="pmcid">PMC6504826</pub-id></mixed-citation></ref><ref id="B146"><label>146</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dintzis</surname><given-names>HM</given-names></string-name>, <string-name name-style="western"><surname>Dintzis</surname><given-names>RZ</given-names></string-name>, <string-name name-style="western"><surname>Vogelstein</surname><given-names>B</given-names></string-name></person-group>. <year>1976</year>. <article-title>Molecular determinants of immunogenicity: the immunon model of immune response</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>73</volume>:<fpage>3671</fpage>&#8211;<lpage>3675</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.73.10.3671</pub-id><pub-id pub-id-type="pmid">62364</pub-id><pub-id pub-id-type="pmcid">PMC431180</pub-id></mixed-citation></ref><ref id="B147"><label>147</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kanekiyo</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Joyce</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Gillespie</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Gallagher</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Andrews</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Yassine</surname><given-names>HM</given-names></string-name>, <string-name name-style="western"><surname>Wheatley</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Fisher</surname><given-names>BE</given-names></string-name>, <string-name name-style="western"><surname>Ambrozak</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Creanga</surname><given-names>A</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2019</year>. <article-title>Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses</article-title>. <source>Nat Immunol</source><volume>20</volume>:<fpage>362</fpage>&#8211;<lpage>372</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41590-019-0395-0</pub-id><pub-id pub-id-type="pmid">30742080</pub-id><pub-id pub-id-type="pmcid">PMC6380945</pub-id></mixed-citation></ref><ref id="B148"><label>148</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Moon</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Suh</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Polhemus</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Ockenhouse</surname><given-names>CF</given-names></string-name>, <string-name name-style="western"><surname>Yadava</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Irvine</surname><given-names>DJ</given-names></string-name></person-group>. <year>2012</year>. <article-title>Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccine</article-title>. <source>PLoS One</source><volume>7</volume>:<elocation-id>e31472</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0031472</pub-id><pub-id pub-id-type="pmid">22328935</pub-id><pub-id pub-id-type="pmcid">PMC3273465</pub-id></mixed-citation></ref><ref id="B149"><label>149</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mehrabi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Montazeri</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Mohamadpour Dounighi</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Rashti</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Vakili-Ghartavol</surname><given-names>R</given-names></string-name></person-group>. <year>2018</year>. <article-title>Chitosan-based nanoparticles in mucosal vaccine delivery</article-title>. <source>Arch Razi Inst</source><volume>73</volume>:<fpage>165</fpage>&#8211;<lpage>176</lpage>. doi:<pub-id pub-id-type="doi">10.22092/ari.2017.109235.1101</pub-id><pub-id pub-id-type="pmid">30280836</pub-id></mixed-citation></ref><ref id="B150"><label>150</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cohen</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>van Doremalen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Greaney</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Andersen</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Sharma</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Starr</surname><given-names>TN</given-names></string-name>, <string-name name-style="western"><surname>Keeffe</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Fan</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Schulz</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Gnanapragasam</surname><given-names>PNP</given-names></string-name>, <string-name name-style="western"><surname>Kakutani</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>West</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Saturday</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>YE</given-names></string-name>, <string-name name-style="western"><surname>Gao</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Jette</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Lewis</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>TK</given-names></string-name>, <string-name name-style="western"><surname>Townsend</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Bloom</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Munster</surname><given-names>VJ</given-names></string-name>, <string-name name-style="western"><surname>Bjorkman</surname><given-names>PJ</given-names></string-name></person-group>. <year>2022</year>. <article-title>Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models</article-title>. <source>Science</source><volume>377</volume>:<elocation-id>eabq0839</elocation-id>. doi:<pub-id pub-id-type="doi">10.1126/science.abq0839</pub-id><pub-id pub-id-type="pmid">35857620</pub-id><pub-id pub-id-type="pmcid">PMC9273039</pub-id></mixed-citation></ref><ref id="B151"><label>151</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cohen</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Gnanapragasam</surname><given-names>PNP</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>YE</given-names></string-name>, <string-name name-style="western"><surname>Hoffman</surname><given-names>PR</given-names></string-name>, <string-name name-style="western"><surname>Ou</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kakutani</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Keeffe</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>H-J</given-names></string-name>, <string-name name-style="western"><surname>Howarth</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>West</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Barnes</surname><given-names>CO</given-names></string-name>, <string-name name-style="western"><surname>Nussenzweig</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Bjorkman</surname><given-names>PJ</given-names></string-name></person-group>. <year>2021</year>. <article-title>Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice</article-title>. <source>Science</source><volume>371</volume>:<fpage>735</fpage>&#8211;<lpage>741</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.abf6840</pub-id><pub-id pub-id-type="pmid">33436524</pub-id><pub-id pub-id-type="pmcid">PMC7928838</pub-id></mixed-citation></ref><ref id="B152"><label>152</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Varela-Aramburu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ghosh</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Goerdeler</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Priegue</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Moscovitz</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Seeberger</surname><given-names>PH</given-names></string-name></person-group>. <year>2020</year>. <article-title>Targeting and inhibiting Plasmodium falciparum using ultra-small gold nanoparticles</article-title>. <source>ACS Appl Mater Interfaces</source><volume>12</volume>:<fpage>43380</fpage>&#8211;<lpage>43387</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acsami.0c09075</pub-id><pub-id pub-id-type="pmid">32875786</pub-id><pub-id pub-id-type="pmcid">PMC7586288</pub-id></mixed-citation></ref><ref id="B153"><label>153</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Xu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Ji</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Shao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>C</given-names></string-name></person-group>. <year>2012</year>. <article-title>Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment</article-title>. <source>Nano Lett</source><volume>12</volume>:<fpage>2003</fpage>&#8211;<lpage>2012</lpage>. doi:<pub-id pub-id-type="doi">10.1021/nl300027p</pub-id><pub-id pub-id-type="pmid">22372996</pub-id></mixed-citation></ref><ref id="B154"><label>154</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Carvalho</surname><given-names>GC</given-names></string-name>, <string-name name-style="western"><surname>S&#225;bio</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>de C&#225;ssia Ribeiro</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Monteiro</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Pereira</surname><given-names>DV</given-names></string-name>, <string-name name-style="western"><surname>Ribeiro</surname><given-names>SJL</given-names></string-name>, <string-name name-style="western"><surname>Chorilli</surname><given-names>M</given-names></string-name></person-group>. <year>2020</year>. <article-title>Highlights in mesoporous silica nanoparticles as a multifunctional controlled drug delivery nanoplatform for infectious diseases treatment</article-title>. <source>Pharm Res</source><volume>37</volume>:<fpage>191</fpage>. doi:<pub-id pub-id-type="doi">10.1007/s11095-020-02917-6</pub-id><pub-id pub-id-type="pmid">32895867</pub-id><pub-id pub-id-type="pmcid">PMC7476752</pub-id></mixed-citation></ref><ref id="B155"><label>155</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gottardi</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Douradinha</surname><given-names>B</given-names></string-name></person-group>. <year>2013</year>. <article-title>Carbon nanotubes as a novel tool for vaccination against infectious diseases and cancer</article-title>. <source>J Nanobiotechnology</source><volume>11</volume>:<elocation-id>30</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/1477-3155-11-30</pub-id><pub-id pub-id-type="pmid">24025216</pub-id><pub-id pub-id-type="pmcid">PMC3846653</pub-id></mixed-citation></ref><ref id="B156"><label>156</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Perrie</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Crofts</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Devitt</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Griffiths</surname><given-names>HR</given-names></string-name>, <string-name name-style="western"><surname>Kastner</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Nadella</surname><given-names>V</given-names></string-name></person-group>. <year>2016</year>. <article-title>Designing liposomal adjuvants for the next generation of vaccines</article-title>. <source>Adv Drug Deliv Rev</source><volume>99</volume>:<fpage>85</fpage>&#8211;<lpage>96</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.addr.2015.11.005</pub-id><pub-id pub-id-type="pmid">26576719</pub-id></mixed-citation></ref><ref id="B157"><label>157</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Doria-Rose</surname><given-names>NA</given-names></string-name>, <string-name name-style="western"><surname>Joyce</surname><given-names>MG</given-names></string-name></person-group>. <year>2015</year>. <article-title>Strategies to guide the antibody affinity maturation process</article-title>. <source>Curr Opin Virol</source><volume>11</volume>:<fpage>137</fpage>&#8211;<lpage>147</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.coviro.2015.04.002</pub-id><pub-id pub-id-type="pmid">25913818</pub-id><pub-id pub-id-type="pmcid">PMC4456294</pub-id></mixed-citation></ref><ref id="B158"><label>158</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jian</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Xiao</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Yisimayi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>An</surname><given-names>R</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2022</year>. <article-title>Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies</article-title>. <source>Nature</source><volume>602</volume>:<fpage>657</fpage>&#8211;<lpage>663</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-021-04385-3</pub-id><pub-id pub-id-type="pmid">35016194</pub-id><pub-id pub-id-type="pmcid">PMC8866119</pub-id></mixed-citation></ref><ref id="B159"><label>159</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Planas</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Saunders</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Maes</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Guivel-Benhassine</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Planchais</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Buchrieser</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Bolland</surname><given-names>W-H</given-names></string-name>, <string-name name-style="western"><surname>Porrot</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Staropoli</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Lemoine</surname><given-names>F</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2022</year>. <article-title>Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization</article-title>. <source>Nature</source><volume>602</volume>:<fpage>671</fpage>&#8211;<lpage>675</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-021-04389-z</pub-id><pub-id pub-id-type="pmid">35016199</pub-id></mixed-citation></ref><ref id="B160"><label>160</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Corbett</surname><given-names>KS</given-names></string-name>, <string-name name-style="western"><surname>Edwards</surname><given-names>DK</given-names></string-name>, <string-name name-style="western"><surname>Leist</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Abiona</surname><given-names>OM</given-names></string-name>, <string-name name-style="western"><surname>Boyoglu-Barnum</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gillespie</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Himansu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sch&#228;fer</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ziwawo</surname><given-names>CT</given-names></string-name>, <string-name name-style="western"><surname>DiPiazza</surname><given-names>AT</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2020</year>. <article-title>SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness</article-title>. <source>Nature</source><volume>586</volume>:<fpage>567</fpage>&#8211;<lpage>571</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-020-2622-0</pub-id><pub-id pub-id-type="pmid">32756549</pub-id><pub-id pub-id-type="pmcid">PMC7581537</pub-id></mixed-citation></ref><ref id="B161"><label>161</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wrapp</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Corbett</surname><given-names>KS</given-names></string-name>, <string-name name-style="western"><surname>Goldsmith</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Hsieh</surname><given-names>C-L</given-names></string-name>, <string-name name-style="western"><surname>Abiona</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Graham</surname><given-names>BS</given-names></string-name>, <string-name name-style="western"><surname>McLellan</surname><given-names>JS</given-names></string-name></person-group>. <year>2020</year>. <article-title>Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</article-title>. <source>Science</source><volume>367</volume>:<fpage>1260</fpage>&#8211;<lpage>1263</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.abb2507</pub-id><pub-id pub-id-type="pmid">32075877</pub-id><pub-id pub-id-type="pmcid">PMC7164637</pub-id></mixed-citation></ref><ref id="B162"><label>162</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pallesen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Corbett</surname><given-names>KS</given-names></string-name>, <string-name name-style="western"><surname>Wrapp</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Kirchdoerfer</surname><given-names>RN</given-names></string-name>, <string-name name-style="western"><surname>Turner</surname><given-names>HL</given-names></string-name>, <string-name name-style="western"><surname>Cottrell</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Becker</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Kong</surname><given-names>WP</given-names></string-name>, <string-name name-style="western"><surname>Andres</surname><given-names>EL</given-names></string-name>, <string-name name-style="western"><surname>Kettenbach</surname><given-names>AN</given-names></string-name>, <string-name name-style="western"><surname>Denison</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Chappell</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Graham</surname><given-names>BS</given-names></string-name>, <string-name name-style="western"><surname>Ward</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>McLellan</surname><given-names>JS</given-names></string-name></person-group>. <year>2017</year>. <article-title>Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>114</volume>:<fpage>E7348</fpage>&#8211;<lpage>E7357</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1707304114</pub-id><pub-id pub-id-type="pmid">28807998</pub-id><pub-id pub-id-type="pmcid">PMC5584442</pub-id></mixed-citation></ref><ref id="B163"><label>163</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tanriover</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Do&#287;anay</surname><given-names>HL</given-names></string-name>, <string-name name-style="western"><surname>Akova</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>G&#252;ner</surname><given-names>HR</given-names></string-name>, <string-name name-style="western"><surname>Azap</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Akhan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>K&#246;se</surname><given-names>&#350;</given-names></string-name>, <string-name name-style="western"><surname>Erdin&#231;</surname><given-names>F&#350;</given-names></string-name>, <string-name name-style="western"><surname>Akal&#305;n</surname><given-names>EH</given-names></string-name>, <string-name name-style="western"><surname>Tabak</surname><given-names>&#214;F</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2021</year>. <article-title>Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey</article-title>. <source>Lancet</source><volume>398</volume>:<fpage>213</fpage>&#8211;<lpage>222</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(21)01429-X</pub-id><pub-id pub-id-type="pmid">34246358</pub-id><pub-id pub-id-type="pmcid">PMC8266301</pub-id></mixed-citation></ref><ref id="B164"><label>164</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Chandrashekar</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Borducchi</surname><given-names>EN</given-names></string-name>, <string-name name-style="western"><surname>Tostanoski</surname><given-names>LH</given-names></string-name>, <string-name name-style="western"><surname>McMahan</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Jacob-Dolan</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Martinez</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>A</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2021</year>. <article-title>Immunogenicity of Ad26.CoV2.S vaccine against SARS-CoV-2 variants in humans</article-title>. <source>Nature</source><volume>596</volume>:<fpage>268</fpage>&#8211;<lpage>272</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-021-03681-2</pub-id><pub-id pub-id-type="pmid">34107529</pub-id><pub-id pub-id-type="pmcid">PMC8357629</pub-id></mixed-citation></ref><ref id="B165"><label>165</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chung</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Kumar</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Arnold</surname><given-names>KB</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>WH</given-names></string-name>, <string-name name-style="western"><surname>Schoen</surname><given-names>MK</given-names></string-name>, <string-name name-style="western"><surname>Dunphy</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Suscovich</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Frahm</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Linde</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Mahan</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Hoffner</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Streeck</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ackerman</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>McElrath</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Schuitemaker</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Pau</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Baden</surname><given-names>LR</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Michael</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Barouch</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Lauffenburger</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2015</year>. <article-title>Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology</article-title>. <source>Cell</source><volume>163</volume>:<fpage>988</fpage>&#8211;<lpage>998</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2015.10.027</pub-id><pub-id pub-id-type="pmid">26544943</pub-id><pub-id pub-id-type="pmcid">PMC5490491</pub-id></mixed-citation></ref><ref id="B166"><label>166</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Miller</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hachmann</surname><given-names>NP</given-names></string-name>, <string-name name-style="western"><surname>Collier</surname><given-names>A-RY</given-names></string-name>, <string-name name-style="western"><surname>Lasrado</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Mazurek</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Patio</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Powers</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Surve</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Theiler</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Korber</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Barouch</surname><given-names>DH</given-names></string-name></person-group>. <year>2023</year>. <article-title>Substantial neutralization escape by SARS-CoV-2 Omicron variants BQ.1.1 and XBB.1</article-title>. <source>N Engl J Med</source><volume>388</volume>:<fpage>662</fpage>&#8211;<lpage>664</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMc2214314</pub-id><pub-id pub-id-type="pmid">36652339</pub-id><pub-id pub-id-type="pmcid">PMC9878581</pub-id></mixed-citation></ref><ref id="B167"><label>167</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Planas</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Bruel</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Staropoli</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Guivel-Benhassine</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Porrot</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Maes</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Grzelak</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Prot</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Mougari</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Planchais</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Puech</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Saliba</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sahraoui</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>F&#233;my</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Morel</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Dufloo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sanju&#225;n</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Mouquet</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Andr&#233;</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Hocqueloux</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Simon-Loriere</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Veyer</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Prazuck</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>P&#233;r&#233;</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Schwartz</surname><given-names>O</given-names></string-name></person-group>. <year>2023</year>. <article-title>Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies</article-title>. <source>Nat Commun</source><volume>14</volume>:<fpage>824</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-023-36561-6</pub-id><pub-id pub-id-type="pmid">36788246</pub-id><pub-id pub-id-type="pmcid">PMC9926440</pub-id></mixed-citation></ref><ref id="B168"><label>168</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Iketani</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Bowen</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Valdez</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Lauring</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Sheng</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>HH</given-names></string-name>, <string-name name-style="western"><surname>Gordon</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Ho</surname><given-names>DD</given-names></string-name></person-group>. <year>2023</year>. <article-title>Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants</article-title>. <source>Cell</source><volume>186</volume>:<fpage>279</fpage>&#8211;<lpage>286</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2022.12.018</pub-id><pub-id pub-id-type="pmid">36580913</pub-id><pub-id pub-id-type="pmcid">PMC9747694</pub-id></mixed-citation></ref><ref id="B169"><label>169</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Viana</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Moyo</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Amoako</surname><given-names>DG</given-names></string-name>, <string-name name-style="western"><surname>Tegally</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Scheepers</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Althaus</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Anyaneji</surname><given-names>UJ</given-names></string-name>, <string-name name-style="western"><surname>Bester</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Boni</surname><given-names>MF</given-names></string-name>, <string-name name-style="western"><surname>Chand</surname><given-names>M</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2022</year>. <article-title>Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in Southern Africa</article-title>. <source>Nature</source><volume>603</volume>:<fpage>679</fpage>&#8211;<lpage>686</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-022-04411-y</pub-id><pub-id pub-id-type="pmid">35042229</pub-id><pub-id pub-id-type="pmcid">PMC8942855</pub-id></mixed-citation></ref><ref id="B170"><label>170</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pajon</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Doria-Rose</surname><given-names>NA</given-names></string-name>, <string-name name-style="western"><surname>Shen</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Schmidt</surname><given-names>SD</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Dell</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>McDanal</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Tong</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Eaton</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Maglinao</surname><given-names>M</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2022</year>. <article-title>SARS-CoV-2 Omicron variant neutralization after mRNA-1273 booster vaccination</article-title>. <source>N Engl J Med</source><volume>386</volume>:<fpage>1088</fpage>&#8211;<lpage>1091</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMc2119912</pub-id><pub-id pub-id-type="pmid">35081298</pub-id><pub-id pub-id-type="pmcid">PMC8809504</pub-id></mixed-citation></ref><ref id="B171"><label>171</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lauring</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Tenforde</surname><given-names>MW</given-names></string-name>, <string-name name-style="western"><surname>Chappell</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Gaglani</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ginde</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>McNeal</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Ghamande</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Douin</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Talbot</surname><given-names>HK</given-names></string-name>, <string-name name-style="western"><surname>Casey</surname><given-names>JD</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2022</year>. <article-title>Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study</article-title>. <source>BMJ</source><volume>376</volume>:<elocation-id>e069761</elocation-id>. doi:<pub-id pub-id-type="doi">10.1136/bmj-2021-069761</pub-id><pub-id pub-id-type="pmid">35264324</pub-id><pub-id pub-id-type="pmcid">PMC8905308</pub-id></mixed-citation></ref><ref id="B172"><label>172</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tegally</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Moir</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Everatt</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Giovanetti</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Scheepers</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Wilkinson</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Subramoney</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Makatini</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Moyo</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Amoako</surname><given-names>DG</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2022</year>. <article-title>Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa</article-title>. <source>Nat Med</source><volume>28</volume>:<fpage>1785</fpage>&#8211;<lpage>1790</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41591-022-01911-2</pub-id><pub-id pub-id-type="pmid">35760080</pub-id><pub-id pub-id-type="pmcid">PMC9499863</pub-id></mixed-citation></ref><ref id="B173"><label>173</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hachmann</surname><given-names>NP</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Collier</surname><given-names>A-R</given-names></string-name>, <string-name name-style="western"><surname>Ventura</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Rowe</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bondzie</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Powers</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Surve</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Hall</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Barouch</surname><given-names>DH</given-names></string-name></person-group>. <year>2022</year>. <article-title>Neutralization escape by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5</article-title>. <source>N Engl J Med</source><volume>387</volume>:<fpage>86</fpage>&#8211;<lpage>88</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMc2206576</pub-id><pub-id pub-id-type="pmid">35731894</pub-id><pub-id pub-id-type="pmcid">PMC9258748</pub-id></mixed-citation></ref><ref id="B174"><label>174</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McMahan</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mercado</surname><given-names>NB</given-names></string-name>, <string-name name-style="western"><surname>Loos</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Tostanoski</surname><given-names>LH</given-names></string-name>, <string-name name-style="western"><surname>Chandrashekar</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Peter</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Atyeo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>A</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2021</year>. <article-title>Correlates of protection against SARS-CoV-2 in rhesus macaques</article-title>. <source>Nature</source><volume>590</volume>:<fpage>630</fpage>&#8211;<lpage>634</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-020-03041-6</pub-id><pub-id pub-id-type="pmid">33276369</pub-id><pub-id pub-id-type="pmcid">PMC7906955</pub-id></mixed-citation></ref><ref id="B175"><label>175</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bartsch</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Zohar</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Fischinger</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Atyeo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Burke</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Edlow</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Fasano</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Baden</surname><given-names>LR</given-names></string-name>, <string-name name-style="western"><surname>Nilles</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Woolley</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Karlson</surname><given-names>EW</given-names></string-name>, <string-name name-style="western"><surname>Hopke</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Irimia</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Fischer</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>Ryan</surname><given-names>ET</given-names></string-name>, <string-name name-style="western"><surname>Charles</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Julg</surname><given-names>BD</given-names></string-name>, <string-name name-style="western"><surname>Lauffenburger</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Yonker</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2021</year>. <article-title>Humoral signatures of protective and pathological SARS-CoV-2 infection in children</article-title>. <source>Nat Med</source><volume>27</volume>:<fpage>454</fpage>&#8211;<lpage>462</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41591-021-01263-3</pub-id><pub-id pub-id-type="pmid">33589825</pub-id><pub-id pub-id-type="pmcid">PMC8315827</pub-id></mixed-citation></ref><ref id="B176"><label>176</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Atyeo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Fischinger</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zohar</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Slein</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Burke</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Loos</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>McCulloch</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Newman</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Wolf</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Shuey</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Feldman</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hauser</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Caradonna</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Schmidt</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Suscovich</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Linde</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Cai</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Barouch</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Ryan</surname><given-names>ET</given-names></string-name>, <string-name name-style="western"><surname>Charles</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Lauffenburger</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Chu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Alter</surname><given-names>G</given-names></string-name></person-group>. <year>2020</year>. <article-title>Distinct early serological signatures track with SARS-CoV-2 survival</article-title>. <source>Immunity</source><volume>53</volume>:<fpage>524</fpage>&#8211;<lpage>532</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2020.07.020</pub-id><pub-id pub-id-type="pmid">32783920</pub-id><pub-id pub-id-type="pmcid">PMC7392190</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>